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campo burocrático, em que serei talvez o pior do mundo!  
A todo Departamento de Biologia Experimental que com os seus defeitos e virtudes 
muito contribuíram para o meu crescimento. 
Ao Pedro Moradas Ferreira e todo seu grupo por me terem ajudado a dar os primeiros 
passos neste intrincado caminho. 
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ABSTRACT 
Oxidative stress has been used to explain phenomena such as cancer progression, 
neurodegeneration and even ageing itself. Its implication in dysfunction and disease has been 
widely described. At a molecular level, oxidative stress means that the levels of oxidants are 
higher than the antioxidants, disrupting cellular signaling and provoking biomolecules damage, 
which are aged cells common features. Proteins are sensitive to oxidation, a cause of their 
dysfunction and accumulation as protein aggregates. Moreover, this insoluble material can alter 
cellular functionality. From previous studies I could verify in oxidative stress challenged human 
lymphocytes that cytoplasmatic actin becomes easily and heavily carbonylated, a non-
enzymatic, irreversible type of protein oxidation. Therefore as a first aim I set to verify whether 
actin carbonylation leads to cellular functional impairment by assessing proliferation rates and 
proteasome activity, the main site for oxidized proteins degradation. 
I could verify that carbonylated actin forms aggregates with direct effect on impairing 
proliferation and diminishing proteasome enzymatic action. Due to the underlying proteostasis 
disturbance, I decided, for the second aim, to address Hsp90. As a molecular chaperone, it is 
involved in keeping a functional proteome; having actin as client protein, Hsp90 assists 
oxidized proteins degradation and protects the 20S proteasome from oxidative inactivation. 
Aiming the role of Hsp90 in actin aggregates formation, I found a likely mechanism for protein 
aggregates formation. This takes part mainly due to Hsp90 cleavage at a very highly conserved 
N-terminal amino acid motif, generating a non-functional N-terminal lacking fragment. I 
confirmed that cleavage antedates oxidized actin accumulation, and also that Hsp90 enhances 
oxidized actin degradation. The data favor the point that Hsp90 cleavage is an important 
precursor for the chain of events that goes from oxidized protein accumulation to proteasome 
inactivation. This consequence appears to be very important for autophagy upregulation that 
follows upon proteasome inhibition and protein aggregates formation. Further studies should 
follow to understand what happens later time points that could allow to have a larger view of the 
problem. Knowing this, procedures to prevent Hsp90 cleavage would perhaps allow cells escape 
oxidative stress harmful effects and retard their entry in senescence like state. 
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RESUMO 
O stress oxidativo tem sido utilizado para explicar fenómenos como o cancro, 
neurodegeneração, e até o envelhecimento. As suas implicações na disfunção e doença têm sido 
largamente descritas. Ao nível molecular, stress oxidativo significa que os níveis de oxidantes 
são superiores aos níveis de antioxidantes, desregulando a sinalização celular e provocando 
danos nas biomoléculas, características estas que são típicas de células envelhecidas. As 
proteínas são sensíveis à oxidação, podendo levar à sua disfunção e acumulação como 
agregados proteicos. Estes agregados tendem a ser insolúveis, podendo alterar a funcionalidade 
celular. Em estudos prévios, consegui verificar que em linfócitos humanos sujeitos a acção 
oxidativa, a proteína citoplasmática actina sofre facil e abundantemente carbonilação, um 
processo irreversível e não enzimático que pode levar à perda de função e em último caso, à 
formação de agregados proteicos. Sendo assim, o meu primeiro objectivo proposto, foi verificar 
se a carbonilação da actina leva a uma diminuição de função celular, através da avaliação da 
taxa proliferativa celular e actividade do proteossoma. Fui capaz de verificar um efeito directo 
de agregados de actina oxidada na diminuição da proliferação e na diminuição da actividade 
enzimática do proteossoma. Devido ao facto de nestas condições oxidativas haver um distúrbio 
na proteostasia, tais como acumulação de agregados de proteínas oxidadas (especialmente de 
actina) e diminuição da actividade do proteossoma, decidi, como segundo objectivo, estudar a 
chaperona molecular Hsp90. A Hsp90 está envolvida na manutenção da proteostasia, tem a 
actina como proteína cliente, tem um papel na degradação de proteínas oxidadas, e protege o 
proteossoma de inativação oxidativa; como tal, propus-me a perceber o papel da Hsp90 na 
formação de agregados de actina. Descobri, um possível mecanismo pelo qual os agregados de 
proteínas oxidadas se poderão formar. Em parte, isto pode dever-se ao facto de haver menos 
Hsp90 funcional em condições de stress oxidativo, devido a clivagem proteolítica, acontece no 
N-terminal da proteína, gerando um fragmento parcialmente funcional. A clivagem foi 
confirmada, e que de facto, antecede a acumulação insolúvel de actina. Foi também confirmado 
o papel da Hsp90 no aumento da degradação de actina oxidada. Estou convencido que a 
clivagem da Hsp90 será um importante percursor numa cadeia de eventos que vai desde a 
acumulação de proteínas oxidadas, passando pela inactivação do proteossoma, e culmina na 
activação de autofagia, um processo verificado aquando da inibição do proteossoma. Contudo, 
mais estudos serão necessários para entender o que se passa mais à frente no modelo, 
possibilitando-nos uma visão mais alargada do problema. Percebendo isto, procedimentos 
experimentais poderão ser desenhados de forma a prevenir a clivagem da Hsp90, o que levaria a 
um melhoramento celular e ao seu retardar na entrada de estadios de senescência ou 
semelhantes a senescência.  
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INTRODUCTION – PART I 
Along Earth´s geological time, evolution tailored living organisms according to 
environmental conditions. 
Around 2 billion years ago oxygen levels had risen up to 18% of our time era. However, 
only 1,5 billion years after this critical event, around 500 million years ago, earth 
witnessed a vast expansion of multicellular life known as the “Cambrian explosion”. 
With it, a major achievement was the expansion of the use of oxygen in aerobic 
metabolism with the inherent increase in the efficiency of cellular energy production. 
As a consequence, more Adenosine TriPhosphate (ATP) was synthesized, to become 
the most important source of energy in living organisms. 
In mammals, the main site for ATP synthesis is the mitochondria, especially its inner 
membrane, which houses enzyme complexes that act as electron carriers. In the final 
processes of nutrient oxidation breakdown that take place in the mitochondrial matrix, a 
large number of electrons are conveyed to reduce NAD (or FAD). These electrons are 
then transported to and released from successive electron carriers, that harness the 
energy they contain and combine with molecular oxygen to produce water. At some 
points of the chain, H+ is moved out of the matrix to the intermembrane space, which 
creates a transmembrane electrochemical gradient; in turn, it promotes proton return to 
the matrix in a way that activates ATP synthase rotation and generates ATP.  
 
1.1 Reactive oxygen species 
The essential role of oxygen is thus to be reduced into a water molecule. Because in its 
ground state, the oxygen outer shell contains two unpaired electrons and both have the 
same spin, oxygen reacts successively with one electron at a time, which precludes the 
production of very reactive molecules. It is estimated however that 1-2% of oxygen 
does not get fully reduced into water; this results in the formation of intermediary 
byproducts, such as superoxide anion (O2-.), with one unpaired electron, which makes 
of it a powerful oxidant, categorized as a reactive oxygen species (ROS). 
This occurs because during aerobic metabolism, electron transfer at the respiratory 
chain is not fully efficient due to leakage at complex I (NADH dehydrogenase) and 
Complex III (cytochrome bc1 complex); the efficiency depends on specific organs or 
cells, and also on the lifespan of the considered species [1]. 
ROS can be categorized as radicals and non-radicals; while radicals have at least one 
unpaired electron, non-radicals are oxidants whose electronic grounds are completed 
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[2]. ROS are unstable, explaining why their activities have short half-lives, that range 
from nanoseconds, as the case of hydroxyl, to minutes, as hydrogen peroxide [3].   
Cells may be affected by endogenous or exogenous ROS (Table 1). The major source of 
endogenous ROS is the mitochondria [4]; however, other sources should be referred as 
they can also produce relevant amounts, or lead to their production, as occurs in nitric 
oxidase reaction, Fenton reaction, arginine metabolism, microsomal cytochrome P450 
detoxification, peroxisomal B-oxidation, respiratory burst (in phagocytic cells) and 
prostaglandin synthesis, among others [5, 6] (Figure 1). Exogenous sources, are 
exemplified by UV radiation X-Rays, gamma-rays, nanoparticles, ultrasounds, 
pesticides/herbicides, metals (Cu, Fe), ozone and xenobiotics [5, 6] (Figure 1).  
In addition, cells can use ROS to participate as second messengers of transductive 
pathways that regulate processes as cytokine secretion, growth, differentiation, gene 
expression, and as active players in immune responses against invading pathogens [7]. 
Moreover, when produced in small amounts, ROS are able to elicit a wide 
spectrum of responses/signaling-pathways to include the JAK/STAT, PI3K/AKT, 
p38, JNK/SAPK and Ras/MEK/ERK1/2 pathways [8]. 
 
1.2 Anti-oxidants defenses 
ROS intrinsic high reactivity is of major concern as it may result in cell damage. 
To cope with that risk, cells evolved anti-oxidant mechanisms that counter-balance ROS 
action and accumulation. One of them is dismutation, performed by superoxide 
dismutases (SOD) including Mn-SOD, present in mitochondria, and Cu-Zn-SOD that 
can be either cytoplasmatic or extracellular. 
SODs promote additional reduction of oxygen to yield hydrogen peroxide, H2O2, a non-
radical. Its reactivity comes from its open conformation, and leads to biomolecule 
oxidation, as will be discussed ahead. While superoxide instability and inability to cross 
membranes limits its effects exerted on cells, hydrogen peroxide diffuses easily across 
membranes [9], a property that is commonly used in cell culture. Additional enzymatic 
resources as catalase or peroxidase are employed to detoxify H2O2 (Table 1). Apart from 
these and other enzymatic processes, cells developed non-enzymatic anti-oxidants, 
some of which are dietary supplements as ascorbic acid (Vitamin C), tocopherol 
(Vitamin E), Zinc, Selenium and carotenoids [5] (Table 1).   
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Table 1. The most common Reactive Oxygen Species and Antioxidants. Cells are exposed to a 
multitude of ROS with different origins, reactivity and stability. To counterbalance oxidants, cells have 
evolved antioxidant defenses. They can be divided in enzymatic (Enz) or non-enzymatic (Non-Enz). 
Some of the most common examples are shown. 
 
 
1.3 Oxidative Stress  
In spite of the detoxifying mechanisms, H2O2 can still be converted into hydroxyl anion 
by transition metal catalysed reactions, as is the case when Fe
2+
 or Cu
+
 ions are oxidized 
(Fenton reaction). It appears that these reactions are a major source of damage [10] 
because hydroxyl is an highly reactive species and a major contributor to oxidative 
stress. This condition is usually referred as an unbalance between anti-oxidants and 
oxidants, that favors the oxidation state. Sies defined it as “a disturbance in the pro-
oxidant / antioxidant balance in favor of the former, leading to potential damage” [11].  
Such damage results from the oxidation of biomolecules as sugars, lipids, DNA and 
proteins. The large array of products formed from their oxidation is strongly dependent 
on the nature of the biomolecule damaged, the oxidant and the biological environment. 
Briefly, oxidation of polysaccharides results in their depolymerization or fragmentation 
[12] but continued oxidation of glycated proteins promotes advanced-glycated end 
products (AGEs) formation and ability to interact with the receptor for AGEs and 
further enhance the oxidative burden upon nearby molecules [5]. Also worth of 
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consideration is the effect of oxidants onto the sugars of nucleotides that lead to their 
carbonylation, ability to bind iron and intensify the Fenton reaction. In addition, ROS 
target nucleotide purines and pyrimidines that result in base deamination, ring openings, 
adduct formation and whole nitrogen base loss, which, together with the failure of 
repairing mechanisms allows the establishment of mutations. Lipids are another class of 
molecules attacked by ROS, where the carbon-carbon double bonds of unsaturated fatty 
acids are an important target. The effects may be relatively limited, or may progress in 
the presence of oxygen to the formation of new peroxyl radicals that may continue new 
rounds of oxidative damage on lipids and produce even more oxidized lipid 
hydroperoxides. Proteins are also markedly affected when oxidized as will be explained 
in the following chapter.  
 
  
Figure 1. Reactive Oxygen Species sources. ROS are an inevitable consequence of daily life. ROS are 
continuously generated by enzymatic or non-enzymatic reactions. Their source can either be endogenous, 
from metabolism and energy-transferring processes, or be exogenous, resulting from exposure to 
environmental contact. Either sources can oxidize proteins, leading to their functional impairment or/and 
accumulation. 
 
A large body of evidence has been generated over the years, showing the correlation of 
oxidative stress consequences and pathologies like cancer [13], neurodegenerative 
disorders, and ageing [11]. In fact, one of the most experimentally tested theories that 
attempt to explain ageing is the Free Radical Theory of Ageing, proposed by Denham 
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Harman in 1956. Since then, the theory has been updated, but its fundamental principle 
has been retained. It postulates that free radical / oxidative stress leads to biomolecule 
error accumulation over time, being a major contributor to the age-related functional 
involution of cells, tissues and organisms [14] (Figure 2). 
 
 
 
Figure 2. How oxidative stress occurs. Across different organisms, young cells have higher levels of 
antioxidants comparing to oxidants, promoting a reduced cellular environment. However, in old cells, 
redox state changes towards oxidation, due to less efficient antioxidant defenses and less efficient 
mitochondria, generating the so called oxidative stress state. As the condition persists, biomolecules such 
as proteins become oxidized which leads to functional impairment and contributes to cell dysfunction. 
Oxidative stress has been linked with disease and ageing progression due to the error accumulation nature 
of the process. 
 
The interplay between oxidative stress, lifespan extension and ageing has been 
documented. In fact, overexpression studies of antioxidant enzymes such as SOD, lead 
to life extension through oxidative stress reduction in mice and Drosophila [15, 16]. 
The accumulation of errors, due to oxidative stress especially in proteins is thought to 
play an important role in the ageing process [14]. The following chapter is focused on 
protein oxidation. 
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2. The special case of oxidative stress: Protein oxidation 
Proteins are an important set of biomolecules affected by ROS. Why should protein 
oxidation be considered so important? Because every cellular process requires the 
involvement of proteins and protein is the main intracellular category of biomolecules, 
making them an easy and reachable target for ROS. 
When the cellular redox state goes beyond physiological levels, protein oxidation is 
likely to occur. The specific features of oxidation depend on the type of ROS, its 
severity (concentration and duration) and the affected amino acid residues [5]. As 
protein structure is maintained by amino acid interactions, their oxidation, thus leads to 
protein structure loss and consequent functional impairment. For example, enzymes, as 
lysozyme and ribonuclease, have been shown to be inactivated by radiation originated 
ROS, particulary when the most effective HO
.
 is involved [17, 18]. 
The affected amino acid residues can be an important markers of extensive oxidation 
damage. Oxidation may be reversible when it involves amino acids such as cysteine and 
methionine, which are highly sensitive to slight increases in ROS levels and originate 
methionine sulfoxide and cysteinyl derivatives respectively. The former can be restored 
back to its reduced form by methionine sulfoxide reductase [19], and the latter can be 
repaired by enzymes such as glutaredoxin or thioredoxin [20] thus reverting oxidative 
conditions. This ability to oxidize and to revert is thought to underlie redox cellular 
signaling [21-23].  
 
2.1 Protein carbonylation – a case of irreversible oxidation 
In contrast to methionine and cysteine oxidation, there is no enzymatic mechanism able 
to revert some types of protein oxidation. Irreversible events occur when ROS oxidizes 
a variety of amino acid residues having aromatic or long side chains, as histidine, 
tryptophan, tyrosine or phenylalanine [24]. Oxidation of other amino acid residues as 
proline, arginine, lysine and threonine results in irreversible carbonyl formation, a 
consequence of major importance due to their quantity and irreversibility [25-29]. 
Therefore its occurrence should be taken as serious in a cellular context. But how 
exactly is protein carbonylation generated?  
Carbonyls can be formed directly by metal catalysed oxidative attack on the amino acid 
side chains of proline, arginine, lysine, and threonine or secondary to lysine, cysteine or 
histidine by reactive carbonyls on carbohydrates (glycoxidation products), lipids, and 
advanced glycation/lipoxidation end products. The more abundant products from 
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carbonylation reaction are glutamic semialdehyde from proline, and aminoadipic 
semialdehyde from lysine.  
Protein carbonylation is an indicator of severe or permanent oxidative damage [30] as 
happens in many disorders that affect cell functioning and survival [10] and following 
exposure to oxidants in experimental conditions [9, 31]. It is not surprising that protein 
oxidation has been related to oxidative stress, disease and aging [10, 32]. In the turn of 
the century Levine and Stadtman gathered data from studies that included tissues from 
organisms at different ages and even whole organisms; they showed that in the last third 
of their lives there was a dramatic increase in carbonylated protein content, thus 
indicating an extensive accumulation that lead the authors to point out that the increase 
in “oxidized proteins rises to a level likely to cause substantial disruption of cellular 
function”[32]. Interestingly, mouse mitochondria carbonylated proteins were decreased 
upon subjecting animals to calorie restriction diet [33], a condition that has been proved 
to prolong certain organism lifespan by activating some intracellular pathways. These 
findings received additional support from studies with old C. elegans [34]. Therefore, 
the correlation of increased levels of carbonylated proteins and aging progression 
suggests an important connection.  
Along the years, our knowledge regarding the correlation of aging and carbonylated 
proteins has increased due to the development of carbonyl detecting techniques. 
Its assessment is currently simplified by the development of techniques as the 
derivatization of carbonyls with 2,4-dinitrophenylhydrazine (DNPH), followed by 
immunodetection with an anti-DNP antibody in a western blot or ELISA assay, or the 
derivatization with biotinhydrazide and detection with fluorescent avidin probes. 
Frequently these procedures are based on 2D gels which amplifies protein resolution 
and allows further analysis as the quantification of protein oxidation level, in relation to 
protein overall content, or its identity employing mass spectrometry, for detailed review 
of methods, see [35]. 
 
2.3 Among the most susceptible proteins to carbonylation is cytoplasmatic actin 
The concept of oxidative stress has evolved. While, in early days, it used to describe 
random damage to the nearby biomolecules, current thinking favors selective damage as 
there is strong evidence for carbonylation specificity in the sense that some proteins are 
more susceptible to be carbonylated compared to others [36]. In fact, susceptibility 
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variation has been seen in different models as plant Arabidopsis thaliana, bacteria E. 
coli, yeast Saccharomyces cerevisiae and even human samples [37-44]. The cause for 
these different carbonylation susceptibilities remain elusive, but explanations have been 
proposed, including ROS and anti-oxidants concentration,  ROS proximity, protein 
structure and location, metal ions binding and protein abundance in cells [45-47]. 
Cytoskeletal protein actin (reviewed elsewhere [9, 48-50]) has been recognized as a 
most susceptible proteins to oxidation. This finding has gathered increased consistence 
and interest in recent years, from in vitro cell free studies, through cells and organisms.  
In vitro, purified actin is oxidized in a way that is dependent on the concentration of the 
oxidant and the time of exposure [51]. Metazoan cysteine 374, at the carboxyl extremity 
of the α actin (or Cys272 in β and  actin) [52] and the yeast actin [53] are very sensitive 
to oxidation due to their localization at or close to the surface of the actin molecule, 
followed by methionine 44, 47 and 355 [50]. Actin oxidation may be elicited by a 
variety of different compounds as chloramines [50], acrolein [54], hypochlorite [51], 
hydrogen peroxide [31, 55] and others [56-59]. 
Although some of these studies were addressing actin changes at the outset, others were 
unexpected observations in different contexts and fields. In fact, it was shown that the 
exposure of different cells or biological samples to oxidative conditions affects a large 
number of proteins, of which actin was found to be a rather sensitive one as evidenced 
by carbonylation assays. 
 
2.4 Settings  
Diet composition, for example, may lead to a variation in actin carbonylation and 
nitrotyrosination [60], suggesting the possibility for its prevention; this point is 
supported by a study on the beneficial effects of including oats in the diet [61]. In 
addition, antioxidants have been studied intensely due to their hampering effect on 
proliferation, albeit the underlying mechanism may differ according to the compound. 
For instance, the use of hops antioxidants as proanthocyanidins resulted in HT29 colon 
cell line proliferation arrest [62], an effect attributed to substantial actin carbonylation 
and cytoskeleton functional impairment. Similar consequence was noted in the 
epithelial Caco-2 cells [63], yeasts upon hydrogen peroxide administration [53] and a 
neuronal cell line after inflammatory cytokine challenge [64]. 
Animal studies on the effects of other stressors and environmental agents on 
carbonylation were also examined in a variety of conditions that emphasized the 
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relevance of cytoskeletal protein oxidation. For example, α-actin from cod fish muscle 
is rather sensitive to ferrous catalyzed oxidation [65] and ferric nitrilotriacetate 
administration to rats results in increased oxidized proteins in gastrocnemius muscle 
[57], whereas the in vivo contact of mussels with environmental pollutants was followed 
by carbonylation enhancement of β-actin in their muscular cells [66]. In a different 
setting, quite unexpected was the detection of carbonylated actin in the serum of pigs 
housed at high density [67], a finding considered a potential stress biomarker. 
 
2.5 Consequences and biological importance 
The progressive modifications on actin molecule have functional consequences. While 
mild oxidation of surface sulfur containing residues has limited effect on actin 
polymerization ability, additional oxidation strongly inhibits it and even enhances its 
fragmentation [51]. 
Moreover, when the intense oxidative insult is continued, actin aggregate formation 
ensues. This was shown in muscle [48] and non-muscle [31].  
The reason for actin susceptibility is not known, as mentioned earlier when protein 
oxidation susceptibility was discussed in a general context. As hypothesized before, one 
reason could be the intracellular content. Actin amounts to 10% of the whole protein in 
normal and leukemic lymphocytes, c. 8% and 5% respectively [68], myeloid leukemia 
cells (5%, [69]), adrenocortical cells (10-12%, [70]) and fibroblasts (7-14%, [71]). 
Another reason is the main localization: it is present throughout the cytoplasm, off the 
lumina of membranous compartments and so easily accessible to diffusible oxidative 
compounds. Finally, actin may have specific structural features that make it more prone 
to oxidation, similarly to other proteins. For example, upon submission of yeasts to 
H2O2, only 8% of the whole yeast protein becomes oxidized, but it amounts to 80% 
when ribosomal protein is considered [72]. In contrast, in E. coli cultures, H2O2 
oxidation targets the protein synthesis factor EF-G [44] and when the cells are grown in 
a medium with a methionine substitute and stressed, the small increase in total 
carbonyls is outweighed by remarkable carbonylation of EF-Tu, the most plentiful 
protein in that bacteria [73]. Similarly, oxidation of arthropod mitochondria results in 
isolated aconitase carbonylation [74]. 
Actin has additional relevance in the context of ageing. In a recent study [75], while 
verifying carbonylation along ageing, the most susceptible proteins were categorized 
according to their involvement in cell functions, they included: glucose metabolism, 
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pyruvate dehydrogenase and tricarboxylic acid cycle, electron transport chain and ATP 
metabolism, plant metabolism, amino acid and protein metabolism, lipid metabolism, 
antioxidant defenses, heat shock proteins/chaperones, receptors and cell signaling, 
membrane transport, plasma proteins and related, and cytoskeleton. Actin was 
highlighted as a sensitive one in yeast, mouse, rat or even human [75]. The recognition 
of actin sensivity to carbonylate, is supported by several lines of evidence, ranging from 
in vitro cell free models through cells and organisms [31, 50-57, 63, 66, 67]. 
Why should this matter? Apart from the enhanced academic interest in recent years new 
areas with notorious medical relevance are being unraveled. Actin participates in a 
number of different and fundamental cell and tissue functions [76] that range from the 
mechanical support for cell shape and muscular contraction, to endocytosis, organelle 
movement, neuronal and immunological synapses and cell movement towards 
chemoattractants [9, 31]. Beyond actin involvement in a large number of cellular 
processes, its study is also important due to the fact that actin has been correlated with 
neurodegenerative diseases, shown by abnormal F-actin accumulation in neuronal death 
conditions [77] and cancer [78].    
Due to its decisive role in cellular functionality, it is important to understand how actin 
is oxidized and how is degraded.  
 
3. Actin and other oxidized proteins fate – proteasome degradation or aggregate 
formation? 
 
3.1 Proteasome degradation 
Non-oxidized proteins have different degradation mechanisms. While some proteins 
have their turnover mechanism well documented others remain obscure. This is the case 
of non-oxidized actin. 
The fate of actin inside cells under physiological non-oxidizing conditions is still 
debatable. For example, what happens to G-actin after F-actin depolymerization and 
dismantlement? To our current knowledge the mechanism whereby F-actin is degraded 
is currently unkown, apart from the involvement in the cycle of F-actin polymerization 
or depolymerization by actin binding protein as gelsolin [79]. 
How G-actin is degraded is currently unsettled too. However, there is evidence that 
three different mechanisms may be operating. The first line of evidence favors caspase-
2 role in G-actin degradation by proteolytic cleavage; in fact, in chick embryonic 
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cardiomyocytes, following lovastatin mediated F-actin disassembly, it was shown that a 
caspase-2 inhibition resulted in actin degradation prevention [80]. Secondly, there is 
evidence from cultured neonatal rat heart cells, demonstrating that when muscle 
contraction was pharmacologically inhibited, α-actin was partially degraded by the 
lysosome [81]. In addtion, actin degradation has been linked to an E3 ubiquitin ligase 
motif-containing 32 (TRIM32) which binds myosin in skeletal muscle and ubiquitinates 
α-actin in vitro. Overexpression of TRIM32 in human embryonic kidney cells lead to a 
decrease in cytoplasmatic actin supporting the involvement of TRIM32 in actin 
degradation [82]. Thus, non-oxidized actin employs different degradation mechanisms 
likely to be preferentially activated in some tissues and according to particular 
functional features. It is a matter that awaits further investigation. In contrast, oxidized 
proteins appear to be an attractive target to the proteasome, the main cellular non-
lysosomal degradation system, following its degradation pathway [83, 84]. The 
proteasome is active in two main forms: one called the 26S, which requires ubiquitin 
tagging and ATP hydrolysis, and the 20S that does not need ubiquitin or either ATP to 
complete the process.  
The 20S structure is a barrel shaped, composed of α and β rings organized in a αββα 
manner; each ring has seven subunits (as α1-α7; β1-β7) (Figure 3). The inner β rings 
responsible for specific proteolytic activity, contain three subunits: β1 for peptidyl-
glutamyl-peptide-hydrolyzing or caspase like activity, β2 for trypsin like activity, and 
β5 for chymotrypsin like activity. The outer α-rings are responsible for substrate 
detection and binding of regulatory complexes such as 11S and 19S which determines 
the activity and the specificity of the proteasome [85]. The combination of 20S with 11S 
or 19S results in the 26S proteasome form. It is involved in the so called Ubiquitin-
Proteasome-System (UPS), and localized in the cytosol and nucleus. 
The ubiquitin part of the system, consists of three types of enzymes: E1 ubiquitin 
activating enzymes, E2 ubiquitin conjugating enzymes and E3 ubiquitin ligases. 
Ubiquitination is a highly ordered and specific mechanism, and due to the diversity of 
existing enzymes is able to form countless possibilities of arrangements.  The process 
starts when the E1 enzymes bind one ubiquitin molecule to its C-terminal glycine; is 
bound to ubiquitin is then transferred to E2 enzymes and, in the last step, ubiquitin is 
bound to E3 enzymes. Depending on E3 enzyme type, ubiquitin is either tagged directly 
to lysine residues in the substrate or indirectly in a two-step mechanism [85]. This form 
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of the proteasome is usually responsible for the degradation of short-lived, not required 
or even misfolded proteins.  
Oxidized proteins seem to be degraded exclusively by the 20S proteasome, the main site 
for oxidized proteins degradation [85-91]. There are three important reasons for such 
preeminent involvement; first, the 20S proteasome itself is relatively more resistant to 
oxidative stress than the 26S [92]; second, oxidized proteins expose hydrophobic 
residues that can act as a trigger signal for degradation independently of ubiquitin 
tagging, not wasting ATP in a cellular stress situation [84, 93]; third, as lysine residues 
are preferential targets of oxidative modification, ubiquitin lysines would be less able to 
bind to substrates and thus, could impair the whole process [45, 85, 86, 94]. It has been 
shown that proteasome inhibition conversely increases the steady state amount of 
carbonylated proteins; this, in fact in post-ischemic rat heart, actin was found to be 
oxidized [95] without actin ubiquitin adducts formation, thus suggesting a 20S 
proteasome-mediated proteolysis [96]. In support, Grune and Davies groups 
demonstrated that the disruption, of the ubiquitin tag system by compromising ubiquitin 
conjugating activity, did not impair the degradation of oxidatively modified proteins 
[94]. 
Despite of 20S proteasome turnover, carbonylated proteins can accumulate during time, 
possibly due to an efficiency decrease or even to oxidized proteins increased rate 
formation. When this happens, protein aggregates can form as it will be described in the 
following chapter. 
  
3.2 Aggregate formation 
In spite of the large number of studies favoring the 20S proteasome role in degrading 
mildly oxidized proteins [84-86] the rate of oxidized proteins formation may be higher 
than the proteasome capacity to promote their turnover. In that case, because 
proteasome may become less functional during a stressful period of time, oxidized 
proteins may accumulate into insoluble protein aggregates, which further inhibit the 
proteasome [31, 97, 98] (Figure 3).  
Changes in protein structure often result in exposure of the usually concealed protein 
core. It is often constituted by hydrophobic residues that upon exposure, enhance 
binding to other oxidized proteins due to its sticky nature; this results in cross-link 
promotion, culminating in insoluble high molecular protein aggregates [25, 30, 98-100]. 
The generation of a Schiff base by the reaction of a carbonyl group from one protein 
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with an amino group from another, adds further to aggregate accumulation and points to 
the interesting aspect of aggregate enlargement without any further oxidation [101]. 
Interestingly, the view that protein aggregates are inert materials has changed. Recent 
data show that they interfere with cell gene expression dynamics, as they can alter 
cellular metabolism at a transcriptional level and even lead to cell death [102, 103].  
Moreover, protein aggregates are a common feature of aged cells [98]. They have been 
deeply correlated with aging progression across different models such as bacteria [39, 
104], yeast [72], C. elegans [34] and mammalian cells [105]. 
 
 
Figure 3. Actin carbonylation and aggregation fate: proteasome 20S or protein aggregates? Native 
actin gets moderately oxidized when cells are challenged with hydrogen peroxide to promote oxidative 
stress. Some of the oxidized actin is degraded by the 20S proteasome; however, because the 20S 
proteasome is also functionally affected, oxidized proteins tend to accumulate. As the stress endures, actin 
becomes heavily oxidized, exposes hydrophobic residues and starts to aggregate. These bind to the 
proteasome, inhibit its proteolytic activity and further disturb the proteasome and cell proliferation.  
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THE ESTABLISHMENT OF HYPOTHESIS AND AIMS 
The data supporting the effect of ageing on tissue carbonylation is varied as evidenced 
in Levine and Stadtman evaluation [10, 32], suggesting that a similar consequence is 
found in tissues of aged humans. To verify this point, collection of tissue from aged 
individuals would be required. However, such samples are hard to obtain due to the 
invasive character of the procedure and early assessments were likely to result in tissue 
loss. As alternative, primary T-cells were isolated from buffy coats obtained during the 
preparation of blood units for transfusion and then submitted to expected oxidative 
conditions employing H2O2. By performing immunoblots after DNPH derivatization, 
the procedure demonstrated a regular pattern of protein carbonylation; a most intense 
band was studied by MALDI-TOF and identified as actin. The results were the core of 
my Master thesis completed in 2008. 
The conditions for actin oxidation and lymphocyte dysfunctional consequences thereof 
became one of the aims in my PhD project. Because of the variability of primary cells, 
the project derived employing a Jurkat T-cell line.  
In Publication I, the establishment of cell culture protocols and the effects following 
H2O2 administration were the central subject. Hydrogen peroxide mediated oxidative 
stress resulted in cell proliferation decrease, an effect accompanied by an enhancement 
in carbonylated actin (also confirmed in cell free extracts). Actin aggregates fed to cells 
were shown to promote their growth arrest too. A decrement in proteasome activity and 
morphological evidence of aggregates was indicative that actin accumulation in 
oxidative conditions results in features of cellular ageing. This was correlated with a 
time-dependent increase in carbonylated actin, but a direct effect was also observed 
when we produced carbonylated actin aggregates in vitro and fed them to Jurkat cells. 
Under these conditions, cells stopped dividing and had their proteasome activity levels 
decreased, which corresponded to what had been observed in hydrogen peroxide 
challenged cells. Therefore, it was concluded, that oxidized actin aggregates are formed 
under oxidative stress, which leads to cell proliferation inhibition and reduced 
proteasome activity. 
The remarkable susceptibility and time-related feature of actin oxidation (Publication I) 
lead us to reason that it might be involved in other oxidative prone conditions due to its 
abundance and cytosolic localization. After a thorough search, we concluded that actin 
carbonylation had been verified in a number of conditions, from cell free systems to cell 
culture, whole organisms study and even apparently distant biotechnological matters as 
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food storage (Publication II); nevertheless, it was our conviction that such extension of 
findings had not generated equivalent interest. 
We reasoned though that, in daily cell life, such actin susceptibility to oxidation and to 
produce harmful accumulation would be balanced by appropriate regulatory 
mechanisms. One of them was the involvement of the proteasome (Publication I), but it 
was an important matter to understand how oxidized actin would be conveyed to it and 
what might happen should the proteasome functional ability become exhausted.   
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Protein carbonylation is a common feature in cells exposed to oxidants, leading to protein dysfunction
and protein aggregates. Actin, which is involved in manifold cellular processes, is a sensitive target
protein to this oxidative modiﬁcation. T-cell proteins have been widely described to be sensitive targets
to oxidative modiﬁcations. The aim of this work was to test whether the formation of protein
aggregates contributes to the impaired proliferation of Jurkat cells after oxidative stress and to test
whether actin as a major oxidation-prone cytoskeletal protein is an integral part of such protein
aggregates. We used Jurkat cells, an established T-cell model, showing the formation of actin aggregates
along with the decrease of proteasome activity. The presence of these protein aggregates inhibits Jurkat
proliferation even under conditions not inﬂuencing viability. As a conclusion, we propose that an
oxidative environment leads to actin aggregates contributing to T-cell cellular functional impairment.
& 2012 Elsevier Inc. All rights reserved.Introduction
Several theories have been proposed to elucidate the reduced
functionality of the immune system during aging but none fully
explain the biology of the process [1]. Although presenescent T
cells are still metabolically active, they have a reduced capacity to
divide after activation [2,3]. Excessive previous proliferation on
chronic stimulation and the consequences of free radicals are
among the most discussed mechanisms explaining this phenom-
enon [4,5].
Among the effects caused by free radical attack protein
carbonylation is a frequent event [6]. Protein carbonylation is a
nonenzymatic process, leading to the formation of an irreversible
product and to protein dysfunction both by changing its correct
folding and by promoting the formation of nonsoluble protein
aggregates [7]. These protein aggregates can in turn modify the
cellular metabolism and inﬂuence cellular functionality [8,9].
Possibly, as a result of a continuous oxidation, protein dysfunction
underlies the age-related involution and, in fact, an enhanced
content in carbonylated protein was observed in the course of
ageing in a number of species [10].
Although, it is assumed that any protein is susceptible to
carbonylation, some may be more susceptible compared to
others [7]. It was suggested, that one of these is actin which,
in vitro, exhibits elevated susceptibility to carbonylation and canll rights reserved.
5
ne).form covalent cross-linking as well as noncovalent aggregates
[11]. Such actin susceptibility was also observed in rat spinal cord
cells [12] and mussel muscular cells [13] and additional actin
ﬁlament disruption and polymerization failure were also noted in
the Caco-2 colonic cell line [14] and yeast [15] when submitted to
oxidative challenge. The data support the point that actin is thus a
protein with a major likelihood to oxidative modiﬁcations. Due to
its ubiquitous presence and variety of actions inside the cells [16],
this would indicate that its oxidation and functional disturbance
might be a common occurrence. However, the diversity of cells so
far studied is rather limited, which does not allow a general-
ization regarding such effect.
To maintain a homeostatic proteome, cells degrade not
required or damaged proteins with the help of the proteasomal
system [17], which is a multicomplex proteolytic machinery
existing mainly in two forms, the ATP-ubiquitin dependent
(26S) and the ATP-ubiquitin independent (20S). Oxidative condi-
tions, such as those leading to protein carbonylation, are known
to result in a decline of ubiquitin-dependent 26S preoteasome
activity, in contrast with 20S proteasome, whose activity is
practically maintained [18]. Interestingly, these effects do not
hinder the cellular ability to degrade carbonylated protein gen-
erated under oxidative conditions. Indeed, all existing data point
to the fact that oxidatively damaged proteins become partially
unfolded due to primary oxidative modiﬁcation, followed by an
exposure of hydrophobic patches which in turn act as a trigger
signal for 20S proteasomal degradation, excluding the need for
ubiquitin tagging [19–21]. In fact carbonylated proteins also
follow this pattern of events [22]. Moreover, actin, after being
J.P. Castro et al. / Free Radical Biology and Medicine 53 (2012) 916–925 917carbonylated, has been described to be degraded by the 20S
proteasome in cardiomyocytes [23]. An unbalance in the pro-
teome homeostasis can occur when the formation of oxidized
proteins outreaches the degrading capacity of the proteasome and
heavily modiﬁed proteins are formed. Under these conditions
cross-linked proteins may be formed and lead to insoluble protein
aggregates. These have been described to act as a proteasome
inhibitor, partially due to the direct binding of the proteasome to
aggregate surface domains resulting in loss of proteasomal
activity [9]. Aggregates appear to induce senescence in some cell
types, resulting in a loss of cell dividing capacity [8,24].
Senescent cells are known to increase in organisms with time,
and immune cells do not seem to be an exception to this
phenomenon. In humans, such changes include reduction of naı¨ve
T-cell production, either CD4þ and CD8þ , and clonal expansion
of speciﬁc CD8 T-lymphocyte subsets as the CD8þCD28– [25].
These CD8þ cells are particularly prone to oxidation [26] and
when grown in vitro, they obtained a senescent like phenotype
including growth arrest, resistance to mitogenic stimuli, altered
cytokine secretion, diminished telomere length, and the loss of
CD28 expression [27].
Here we test the hypothesis that the formation of protein
aggregates and the resulting inhibition of proteasome also take
place in immune cells, therefore contributing to the reduced
proliferation ability of T cells. We were able to demonstrate the
formation of protein aggregates already at low doses of oxidative
stress, the inhibitory effect on the proteasome, and, furthermore,
we were able to show that carbonylated actin is a major
component of these aggregates.Materials and methods
Cell viability/proliferation
Jurkat cells (6105 cells/ml) were allowed to adapt in 75-mm
culture ﬂasks containing RPMI 1640 (Biochrome), with 10% FBS,
1% L-glutamine, 1% penicillin/streptomycin at 37 1C, 5% CO2 in a
Nuairetm US Autoﬂow CO2 water-jacketed for 3 days. They were
then divided and 6105 cells/ml were cultured in the same
medium under seven different conditions: controls, 6.25, 12.5, 25,
50, and 100 mM H2O2 or 1 mM lactacystin (Invitrogen) for a
variable time depending on the experiments described below.
Cell suspensions from each ﬂask were mixed with trypan blue
(1:1) and evaluated in an automated cell counter (Invitrogen) for
cell viability and proliferation (cell number).
Immunoblotting
Cells cultured in the RPMI 1640 medium, as above, were
submitted to oxidation by adding 6.25, 12.5, 25, 50, and 100 mM
H2O2 for 3 or 24 h, and for another set of experiments to 1 mM
lactacystin, 100 mM H2O2, and both combined. They were
counted, and an equal number (8105 of cells) were lysed
directly in a lysis buffer (glycerol 12.5%, 6.25 mM Tris, pH 6.8,
SDS 5%, bromophenol blue 0.08%), brieﬂy sonicated, and boiled at
65 1C for 20 min. The same volume (20 ml) from each sample was
loaded and resolved in a 10% SDS-PAGE gel. Proteins were blotted
onto Hybond membranes (Amersham Biosciences Europe) (equal
concentration of protein in each lane was conﬁrmed by staining
the membrane with Ponceau solution). When the experiment was
performed to detect protein carbonylation, the membranes were
directly derivatized with 2,4-dinitrophenylhydrazine (DNPH,
Sigma Aldrich). Brieﬂy, after the transfer, the membranes were
equilibrated in TBS (Tris buffer saline)/20% methanol, washed for
5 min in 10% triﬂuoroacetic acid (TFA, VWR), incubated for 10 minwith 5 mM DNPH/TFA (10%) in the dark, washed with TFA (10%)
to remove the excess of DNPH, and ﬁnally washed again ﬁve
times (5 min each) with 50% methanol. Following this, mem-
branes were blocked with 5% BSA/TBST (Tris buffer saline with
Tween 20, 0.1%) for 1 h.
After blocking, the membranes were probed with rabbit IgG
anti-DNP (Sigma) at a 1:10,000 dilution as the primary antibody,
goat IgG anti-actin (Abcam) at a 1:750 dilution, and rabbit anti-b5
proteasome subunit at 1:1000 (Abcam). For the secondary anti-
bodies, IRDye 680LT goat anti-rabbit IgG, IRDye 800CW goat anti-
rabbit IgG, and IRDye 800CW donkey anti-goat IgG from Li-Cor
were used. The detection was performed by infrared, using the
Li-Cor equipment from Odyssey. Band intensities were quantiﬁed
by densitometry using Odyssey software. Graphics were made
using GraphPad Prism 5 software.
Immunocytochemistry
Cells were grown on 6-well plates for 24 h, and after washing
in PBS, they were placed on poly-L-Lysine slides (Jurkat are
suspension cells) and allowed to dry in the incubator described
above (see Cell viability/proliferation). Immediately after, they
were ﬁxed in 4% paraformaldehyde, washed with PBS, PBST
(phosphate buffer saline with Tween 20 0.1%), and PBSTx
(phosphate buffer saline with Triton X 0.1%) 0.1%, and incubated
for 1 h in PBST/BSA 2%, to lower unspeciﬁc background signal;
however, for the experiments detecting carbonylated proteins,
before the blocking step, cells were incubated in with 5 mM
DNPH for 10 min, and to neutralize the reaction 2M Tris was used.
Afterward, cells were incubated overnight at 4 1C with a solution
containing the primary antibodies, 1:250 of goat anti-b-actin
from Santa Cruz (USA) and/or 1:1000 of rabbit anti-DNP from
Sigma, 1:1000 of mouse anti-CFTR from R&D Systems (USA),
1:100 of rabbit anti-b5 proteasome subunit from Abcam. After
washing twice in PBST, cells were incubated with the secondary
antibodies conjugated with Alexa ﬂuorochromes from Molecular
Probes, donkey anti-goat secondary antibody conjugated with
Alexa 488 and 568 (1:1000 prepared in PBST with 2% BSA) and
with anti-rabbit secondary antibody conjugated with Alexa 488
and 568 (1:1000 prepared in PBST with 2% BSA) and donkey anti-
mouse secondary antibody conjugated with Alexa 568 (Molecular
Probes) 1:750 prepared in PBST with 2% BSA). Fluorescence
samples were analyzed on a Zeiss AxioImager Z1 ﬂuorescence
microscope in Porto, Portugal, and a Zeiss Axiovert in Jena,
Germany. For phalloidin staining experiments, actin-stain 488
ﬂuorescent phalloidin was purchased from Cytoskeleton Inc.
The same protocol as above was used until the blocking step.
Cells were incubated with 100 nM phalloidin for 30 min in the
dark, washed three times in PBS, and analyzed in a Zeiss LSM 510
confocal microscope, also in Jena, Germany, with help from
Dr. S. Monajembaschi, Fritz Lippman Institute, Jena.
Proteasome activity
Cells were counted, and the same number of cells was washed
twice with PBS in each tube. Cells suspensions were centrifuged
for 5 min at 30g and lysis buffer (250 mM sucrose, 25 mM Hepes,
10 mM magnesium chloride, 1 mM EDTA, and 1.7 mM dithio-
threitol (DTT)) was added to the pellet. Cells were lysed using a
20-gauge syringe, followed by repeated freeze–thaw cycles. After-
ward, the cell lysates were centrifuged at 3500g for 30 min and
the supernatants were used for determination of proteasomal
activity. Samples of the supernatants were incubated in 225 mM
Tris buffer (pH 7.8), 45 mM potassium chloride, 7.5 mM magne-
sium acetate, 7.5 mM magnesium chloride, and 1 mM DTT.
To measure chymotrypsin-like activity of the proteasome the
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ﬁnal concentration of 200 mM. Samples were incubated for
30 min at 37 1C. The proteolytic MCA liberation was measured
using a ﬂuorescence reader (Reader EL 340; Bio Tek Instruments,
Bad Friedrichshall, Germany) at 360 nm excitation and 460 nm
emission. Free MCA was used as the standard for quantiﬁcation.
Actin aggregate formation in vitro
Puriﬁed, nonmuscle, 232.56 mM actin (Cytoskeleton, Inc.) was
suspended in distilled water. A volume of 10 ml totaling 50 mg of
actin was mixed with 10 ml of general actin buffer (GAB,
Cytoskeleton, Inc.) supplemented with 5% sucrose, 1% dextran
and 0.2 mM ATP, purposed to stabilize protein and prevent
unwanted aggregation. Samples were incubated on ice for 1 h to
depolymerize actin oligomers that may have formed during
storage or resuspension. After incubation for 1 h, 5 ml of samples
was mixed with GAB þ H2O2 (1:1) to obtain ﬁnal concentrations
of 1, 0.5, and 0.1 mM of hydrogen peroxide. Next, samples were
mixed for 30 min at 300 rpm at room temperature. Twofold gel
loading buffer was added 1:1 (composition described in Immuno-
blotting), and samples were heated to 65 1C for 20 min. Sample
aliquots of 5 ml were loaded and analyzed in a 10% SDS-PAGE gel,
followed by silver staining.
Silver staining
At the end of the electrophoresis, gels were ﬁxed in 30%
ethanol (Merck)/10% acetic acid (Merck) for no less than 2 h.
Next, gels were washed in 20% ethanol and distilled water for
10 min each. For sensitization, sodium thiosulfate 0.2 g/L was
used for 1 min followed by two quick washes in distilled water.
Gels were incubated in a silver nitrate solution (2 g/L, Sigma) for
10 min in the dark room. To develop protein bands, 700 ml 37%
formaldehyde (Merck), 30 g sodium carbonate (Merck), and 5 ml
sodium thiosulfate were mixed to a ﬁnal volume of 1 L.
The development was stopped using Tris (Sigma) 50 g/L and
2.5% acetic acid. Silver-stained gel images were captured using
ChemiDoc equipment.
Actin aggregates incubation with Jurkat cells
Actin aggregates were produced as described above in Actin
aggregates formation in vitro. Using 96-well plates, Jurkat cells
(6105 cells/ml) were placed in contact with puriﬁed aggregates
(1–2%) for 24 h. Proliferation and viability indexes were
obtained using the same method described above (Cell viability/
proliferation).
Peptide mass ﬁngerprinting
Silver-stained gel bands of protein aggregates were cut out
from the gel, destained by a ﬁrst wash of 50 mM ammonium
bicarbonate (ABC)/5% acetonitrile (ACN) and two additional
washes of 50 mM ABC/50% ACN. Afterward gel pieces were dried
with 100% ACN, and then rehydrated with a 10 mg/ml trypsin
solution (Promega, Madison, WI, USA, sequencing grade) over-
night at 37 1C. Peptide was extracted by a 60% ACN/0.1% triﬂuor-
oacetic acid (TFA) solution (twice). Protein digests were desalted
and concentrated using ZipTips (Millipore, Bedford, MA, USA)
following the manufacturer instruction. Samples were applied
onto a stainless-steel 192-well MALDI plate using the dried
droplet method. For the matrix, a solution of 5–10 mg/ml
cyano-4-hydroxycinnamic acid in 50% ACN/0.1% TFA was used.
Samples were analyzed at the Proteomics Unit of IPATIMUP
(Porto, Portugal) using the 4700 proteomics analyzer MALDI-TOF/TOF (Applied Biosystems, Foster City, CA, USA). Peptide mass
ﬁngerprint data were collected in positive MS reﬂector mode in
the range of 700–4000 mass-to-charge ratio (m/z) using 1000–
3000 laser shots for each sample and were calibrated internally
using trypsin autolysis peaks. Several of the highest intensity
nontrypsin peaks were selected for tandem MS (MS/MS) analysis.
Air, at 9107, was used as the collision gas for MS/MS and the
collision energy was set at 1 kV. Data from 3000 to 5000 laser
shots were collected. The spectra were analyzed using GPS
Explorer (Version 3.6; Applied Biosystems), which acts as an
interface between the Oracle database containing raw spectra
and a local copy of the Mascot search engine (Version 2.1.04).
The MS and MS/MS data were searched together against a locally
stored copy of the NCBInr and SwissProt using the Mascot search
engine. The search included peaks with a signal-to-noise ratio
greater than 10 and allowed for up to two missed trypsin cleavage
sites. To be considered a match, a conﬁdence interval (CI),
calculated by Applied Biosystems GPS Explorer (GPS), of at least
95% was required. The closer a conﬁdence interval is to 100%, the
higher the probability that the identiﬁcation is correct.Results
Proliferation Is impaired under oxidative stress conditions
but not viability
To evaluate the viability and proliferation rate, Jurkat T cells
were submitted to oxidative conditions using hydrogen peroxide
at various concentrations and analyzed up to 72 h (see Materials
and methods for details). Viabilities were high for all groups
(above 90%) and did not show signiﬁcant differences between
control and treated cells, suggesting that a noncytotoxic concen-
tration of hydrogen peroxide was used (see supplementary
material Fig. S1A).
Actin carbonylation and aggregation in Jurkat cells
In order to test whether protein carbonylation already takes
place at the used oxidant concentrations, we measured protein
carbonylation by immunoblot. Interestingly, we observed a major
DNPH-positive band at 42 kDa. Due to the known susceptibility of
actin to carbonylation [11, Castro and Almeida, unpublished data]
and the molecular weight of the major carbonylated band, we
assumed this to be actin and performed an identiﬁcation using an
anti-actin antibody. By using the double channel infrared Li-Cor
instrument we could verify an absolute match of the protein
bands. Surprisingly, the carbonylation intensity of actin declined,
rather than increased, with increasing concentrations of H2O2
(Fig. 1A). However, the amount of actin was also decreased
dramatically, indicating a clear concentration-dependent loss of
the protein after 24 h (Fig. 1A).
Possible explanations for this result could be either the
degradation of actin by the proteasome or the formation of high
molecular aggregates. Both processes are taking place within
several hours after oxidative stress, in most tested cells in a time
frame from 3 to 24 h [22,28–30]. Therefore, we tested whether
the actin loss is taking place already in an early time frame.
As demonstrated in Fig. 1B no loss of actin could be observed
within 3 h after starting the oxidative challenge. Under moderate
oxidizing conditions also no dramatic increase of actin carbonyla-
tion was observed (Fig. 1B). As already noted one explanation for
the later reduction of the actin content would be that the stress-
related action carbonylation leads to the formation of high
molecular weight protein aggregates, thereby reducing the actin
levels at the molecular weight range of 42 kDa. In order to test
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Fig. 1. Carbonylated actin aggregates formation is time and concentration dependent. Actin carbonylation following exposure of Jurkat cells to hydrogen peroxide for 24
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of actin (black columns) and the carbonylated bands (gray columns) from three independent experiments (mean 7 SD are shown). Membranes were probed against DNP
and b-actin (see Materials and methods). (A–D) Immunoblots from top to bottom: immunoblots for actin, carbonylated proteins (CP), and the respective merged blot;
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weight fraction in the stacking zone of the immunoblot. As
demonstrated in Fig. 1C we could clearly identify a signal of
protein carbonyls and actin in the stacking gel. This signal
increased with increasing concentrations of hydrogen peroxide
24 h after the stress, indicating a shift of actin toward the high
molecular weight zone. Interestingly, such protein aggregates
cannot be observed 3 h after exposure (Fig. 1D), which is in
accordance with the remaining band intensity of actin at 42 kDa
at this time point.
Considering these results, we speculate that actin aggregation
is obviously a major factor in the loss of functional actin.
However, since the proteasome is able to degrade preferentially
proteins which are oxidized, we decided to test the role of the
proteasome in the degradation of oxidized actin.
Proteasome inhibition favors actin aggregate formation
Since we observed a most dramatic decrease in actin and actin
carbonylation levels 24 h after treatment with 100 mM H2O2accompanied by an increase in actin aggregates, our next step
was to conﬁrm that actin was actually mainly aggregating and not
being degraded. To achieve this we inhibited the proteasome with
lactacystin, and after viability indexes and proliferation measure-
ments (supplementary material Fig. S2) we decided to employ the
proteasome inhibitor lactacystin (LC) during hydrogen peroxide
treatment. Since high concentrations of lactacystin under our
conditions are toxic to Jurkat cells we used a concentration of 1
mM lactacystin. As demonstrated in Fig. 2B such a low concentra-
tion of lactacystin already decreases signiﬁcantly the activity of
the proteasome by some 25%, without affecting the amount of the
proteasome. In order to test whether lactacystin addition is
inﬂuencing the loss of the actin band, we performed an actin
immunoblot with and without hydrogen peroxide and lactacystin.
As demonstrated in Fig. 2A (42-kDa band) no signiﬁcant changes
due to lactacystin levels in the controls or hydrogen peroxide-
treated cells were observed. However, as already demonstrated in
Fig. 1A, a loss of actin occurs due to hydrogen peroxide treatment.
With this new set of experiments, we noted two major zones of
actin localization in the high molecular range: one in the stacking
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J.P. Castro et al. / Free Radical Biology and Medicine 53 (2012) 916–925920zone, already noted in Fig. 1C and D, and one in the high
molecular weight of 150–250 kDa exhibiting colocalization with
protein carbonyls. It is clearly visible that the quantiﬁcation of
both zones revealed that they are increasing dramatically due to
hydrogen peroxide treatment, independently of proteasome
inhibition.
Since hydrogen peroxide treatment increases protein aggrega-
tion with little or no effect of proteasome inhibitor lactacystin, we
decided to test for proteasomal activity. As already noted lacta-
cystin reduced the proteasomal activity by some 25%. However, as
demonstrated in Fig. 2B hydrogen peroxide treatment reduced
the proteasomal activity by some 50% after 24 h. Next we decided
to test whether the reduced proteasomal activity is due to a
reduced expression. As demonstrated in Fig. 2B the expression of
the b5 subunit is not changed due to lactacystin or hydrogen
peroxide treatment. Since it is known that the 20S proteasome is
largely resistant to oxidative stress, at least compared to the 26S
[18], we proposed that protein aggregates are a major factor in
reducing the proteasomal activity, as shown earlier [8,9]. Never-
theless, to make sure that the aggregates were held responsible
for this decrease, we checked for proteasome activity at time
points where no relevant aggregation took place. So we tested the
proteasomal activity at the 3 h time point, where we could
observe no signiﬁcant aggregate formation (see Fig. 1). At this
time point the proteasomal inhibition by lactacystin (80% inhibi-
tion) exaggerates clearly the inhibition by hydrogen peroxide
(35% inhibition), whereas this relation turns vice versa at 24 h
(see Fig. 2B). Since there is no aggregation at the 3 h time point,
we attribute the ongoing proteasome inhibition at later timepoints (24 h) to protein (actin) aggregation. These data provide
evidence that proteasome activity inhibition, not its protein level,
is the mechanism that allows the accumulation of carbonylated
actin and makes it prone to form aggregates in these cells.
Actin aggregates colocalize to the proteasome
In order to test whether the decrease in the proteasomal
activity could be related to interaction of actin aggregates with
the proteasome, we used an immunocytochemical assay with
antibodies against actin and the proteasomal b5 subunit in
control and 100 mM H2O2-treated cells. Treated cells displayed
one or more dense spots with intensive actin labeling which, most
interestingly, colocalized with the proteasome (Fig. 2C). This
suggests a binding between actin aggregates and the proteasome.
This was not seen in control cells, which exhibited a delicate
homogeneous distribution of actin and a uniform proteasome
labeling (Fig. 2C). Taking these results into account, it seems that
the proteasome does lose its activity by binding to actin
aggregates.
Actin aggregates as a result of oxidative challenge
After noting that oxidative stress induced actin aggregation in
Jurkat cells, we decided to analyze these aggregates further by
immunocytochemistry. First, we could clearly demonstrate that,
as expected, the main amount of carbonylated proteins is found in
the cytosol (Fig. 3A), as already reported earlier [31,32]. Interest-
ingly, the distribution is not even as reported for other cell lines,
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Fig. 3. Actin aggregates in aggresomes. For each panel upper and bottom images are from control and 100 mM H2O2, respectively, and are taken after 24 h of exposure to
hydrogen peroxide. Localization of protein carbonyls and DNA (A); actin and DNA (B) and actin and protein carbonyls (C) are shown on the left panels. The right panels
show the colocalization of CFTR, an aggresome marker protein, with DNA (D), protein carbonyls (E), and actin (F). Arrows indicate the presence of protein aggregates/
aggresomes. Images captured with a ﬂuorescence microscope (see Materials and methods).
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could clearly show that actin shows the same uneven distribution
pattern after treatment with hydrogen peroxide (Fig. 3B) and in
colocalization studies a clear colocalization of actin and the
protein carbonyls was found (Fig. 3C). This conﬁrms the results
of our electrophoretic studies (Fig. 1 and Fig. 2A) where an
aggregation of carbonylated actin was suggested. For several
years it is known that damaged proteins might accumulate in
structures called aggresomes [33] and that CFTR (cystic ﬁbrosis
transmembrane conductance regulator) is a marker of aggre-
somes [33,34] we decided to test the colocalization of protein
carbonyls and actin with CFTR (Fig. 3D–F). A clear colocalization
can be found in hydrogen peroxide-treated cells between CFTR
and carbonylated actin aggregates. Taking these results into
account, there seems to be sufﬁcient evidence in favor of
carbonylated actin aggregating in aggresomes and binding to
the proteasome, therefore reducing the functional capacity of
the proteasomal system.Oxidative stress leads to F-actin rearrangements
Following actin aggregate mass veriﬁcation in Fig. 3, we
wanted to check in which way the cytoskeleton arrangement
would be affected. To achieve that we stained cells with phalloi-
din, a high afﬁnity drug for F-actin. Using confocal microscopy
and Z-stack settings, which seemed the best approach for struc-
tural ﬁndings, we can see by visualizing (Fig. 4) that there are
notorious differences between control and hydrogen peroxide-
treated cells. Control cells exhibit normal actin display occupying
almost the entire periphery of the cell. This was not seen in
treated cells that showed not only major F-actin aggregates, but
cellular zones devoid of F-actin. These results conﬁrm the earlierresults of actin aggregate formation and showed that actin
condensation leads to cytoskeleton rearrangements.
Oxidative stress leads to an irreversible growth arrest state
Our initial attempt was to test whether low dose oxidative
stress might impair the cellular function of Jurkat cells. As seen in
Fig. 5, under the tested conditions the cells are viable, but due to
malfunction of the proteasomal system are forming aggresomes
with F-actin as a major component (Figs. 2–4). In order to test
whether the presence of protein aggregates also under nontoxic
conditions inﬂuences the dividing ability of the Jurkat cells, we
performed proliferation experiments. In Fig. 5A it is clearly visible
that hydrogen peroxide-treated cells are losing their dividing
ability in a concentration-dependent manner. Also 72 h after the
start of the oxidative challenge the proliferating ability had not
recovered. However, since the loss of proliferation might be due
to the loss of some essential (perhaps reducing) components in
the cells or the surrounding media, we decided to perform an
additional set of experiments and changed the cell culture media
after 72 h and monitored cellular proliferation for some 72 h.
As shown clearly in Fig. 5B the oxidatively challenged Jurkat cells
did not regain proliferation, even under optimal new growth
conditions. This permanent inhibition in proliferation we attribu-
ted to the persistent presence of protein aggregates in Jurkat cells.
In vitro-formed actin aggregates inhibit the proteasome and block
Jurkat proliferation
To reveal some mechanistic evidence to demonstrate the
leading role of actin aggregates in inhibiting the proteasome
and interfering with Jurkat proliferation, we decided to produce
actin aggregates in vitro, employing a puriﬁed nonmuscle actin.
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Fig. 5. Proliferation of Jurkat cells is impaired by hydrogen peroxide treatment and protein aggregates. Jurkat cells were treated with the indicated concentrations of
hydrogen peroxide. (A) Cells were cultivated and after the indicated time points cells were harvested and counted. In panel B the same experiment was performed, with
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Fig. 4. F-actin redistribution after hydrogen peroxide treatment. Jurkat cells were cultured as described above under control conditions or with 100 mM H2O2 treatment.
Using the speciﬁc F-actin staining phalloidin, images show uniform F-actin display in control cells, but not in cells treated with hydrogen peroxide. Actin aggregates can be
visualized (shown by the arrow); also worthy of note are cellular zones apparently lacking actin, which seems to be condensed in aggregates. Z-stack images captured from
a confocal microscope (see Materials and methods). Cells were analyzed in 16 Z-stacks each 0.55 mm wide. Stacks 6 to 9 are shown. Arrows indicate the presence of actin
aggregates/aggresomes.
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peroxide results in a 42-kDa normal actin band intensity
decrease. Conversely, several bands of protein appear above 75
kDa. Peptide mass ﬁngerprint provided clear evidence that they
were composed of actin (data not shown). In contrast to the study
with Jurkat cell extracts, aggregates were absent from the stack-
ing zone of the gel in this experiment, suggesting a further
processing of initial actin aggregates in cells.
Next we tested whether these in vitro-formed aggregates are
taken up by Jurkat cells, as reported for other cell types [8]. After
incubation of Jurkat cells with actin aggregates for 24 h, we
performed an immunocytochemistry staining technique against
actin. As shown in Fig. 6B, control cells exhibited a typical
uniform distribution throughout the cell, already seen in Fig. 4,
and cells incubated with nonoxidized actin showed a similar
distribution. However, cells incubated with oxidized actin/actinaggregates showed clearly the accumulation of actin aggregates
as seen previously in 100 mM H2O2-treated cells (Fig. 4) and
indicating cellular actin aggregate uptake.
The uptake of actin did not inﬂuence the cell viability (Fig. S3).
However, in these treated cells we could clearly demonstrate a
decline of the proteasomal activity with some remaining 70% of
the chymotrypsin-like activity after 24 h incubation of Jurkat cells
with oxidized actin. This decline was not accompanied by changes
in the amount of the b5-proteasomal subunit (data non shown).
Next we tested, whether the accumulation of actin aggregates—
without exposing the cells to hydrogen peroxide—is inﬂuencing
the cellular proliferation of Jurkat cells. Cells treated with oxidized
actin/actin aggregates for 24 h lost proliferating ability as well as
hydrogen peroxide-treated cells (Fig. 6C). None of the controls
(GAB buffer or nonoxidized actin) are able to inﬂuence cell
proliferation. This indicates that actin aggregates mimic the ability
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J.P. Castro et al. / Free Radical Biology and Medicine 53 (2012) 916–925 923of H2O2 to cause growth arrest (Fig. 6C). Taking these results into
account, we can clearly conclude that artiﬁcial actin aggregates can
directly affect normal cellular processes such as proliferation and
proteasome activityDiscussion
Within the damage provoked by exposing biomolecules to free
radicals, proteins account for a major target, resulting often in
J.P. Castro et al. / Free Radical Biology and Medicine 53 (2012) 916–925924protein carbonylation. There seems to be different protein sus-
ceptibilities to carbonylation, but one protein that has been
widely described as a sensitive one is actin [11]. Its ubiquity
and cellular abundance not only in human cells but in several
other organisms, and its involvement in manifold cellular pro-
cesses, such as motility [35], adherence [36], gene expression
[37], immunological synapse [38], cell secretion [39], and cell
division [40], make actin a relevant target of study. In fact,
alterations in the structure and dynamics of the cytoskeleton
have been reported in many age-related diseases such as cancer
[41] and neurodegenerative disorders [42].
In this work with a T-cell model, we have shown the suscept-
ibility of actin to aggregation. Together with the known effects of
protein aggregates on cellular processes, we hypothesize a role of
actin aggregation in the diminishment of T-cell functionality,
namely proliferation. Our data suggest a two-way event for actin
aggregates formation, following the general mechanism proposed
by Jung et al. [32]: the oxidative attack leads ﬁrst to a slight
protein oxidation, causing misfolding in the native protein state;
if the stress persists, further oxidation aims at the hydrophobic
residues that are normally buried inside proteins and these
become heavily oxidized, which favors the formation of protein
aggregates.
To cope with and prevent the accumulation of oxidized
proteins, which can lead to an imbalance of the proteome,
they are normally degraded by the proteasome. However, this
process may be impaired when the rate of oxidized protein
formation exceeds proteasomal capacity or when the protea-
some itself has a decreased activity. In fact, Das et al. [43]
showed a loss of catalytic activity of the proteasome, following
exposure to prooxidants, resulting in a decline in activation-
induced proliferation and an increase in the accumulation
of carbonylated proteins. These data perfectly ﬁt with
our results evidencing decreased proteasome activity and cell
proliferation in oxidatively challenged cells. In addition,
we observed carbonylated actin aggregates and, furthermore,
we were able to make an immunocytochemical colocalization of
the aggregates with the proteasome, an additional support
to the view that they contribute to proteasome inhibition and
the decline of its proteolytic activity. To support our view, we
were even able to show a direct effect of artiﬁcial actin
aggregates in proliferation and proteasome activity. In Fig. 7
we summarized our working scheme on the role of oxidative
stress in the formation of actin aggregates. If native actin is
exposed to oxidants it becomes moderately oxidized. At the
same time, oxidative stress impairs the proteasome [18]; how-
ever, some of the oxidized actin is degraded. But as the stress
persists, and because the proteasome was momentarily inhib-
ited, it allows heavily oxidized actin to start aggregation.
The formed aggregates interact with the proteasome, inhibit
its activity, and lead to a loss of Jurkat functionality, e.g.,
proliferation.
In fact, a decreased proteasome-mediated degradation has
been shown in T cells from elderly people and was thus proposed
to play a role in immunosenescence [44]. In addition, studies by
Chondrogianni et al. pointed out that the inhibition of the
proteasome promotes the induction of a senescent state, while
the stable expression of some proteasome subunits results in
increased proteasome activity and cell survival following oxidants
exposure [45].
So, as a conclusion, we propose that actin aggregates con-
tribute to T-cell functional impairment, in part, by inhibiting the
proteasome activity. We also hypothesize that actin’s ability to
form high molecular aggregates is extended to other cells, such
as brain and skeletal and heart muscle, with similar functional
outcome.Acknowledgments
J.P.C. was supported by a short term PhD scholarship for
doctoral studies from the Deutscher Akademicher Austausch
Dienst (DAAD). J.P.C was also supported by an European grant
of the COST Action CM1001 - Chemistry of non-enzymatic protein
modiﬁcation - modulation of protein structure and function for a
short term scientiﬁc visit. We would like to thank Dr. S. Mon-
ajembaschi from Fritz Lippman Institute, Jena, for helping us with
the Confocal Microscope.Appendix A. Supporting information
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.freeradbiomed.
2012.06.005.References
[1] Shanley, D. P.; Aw, D.; Manley, N. R.; Palmer, D. B. An evolutionary
perspective on the mechanisms of immunosenescence. Trends Immunol.
30:374–381; 2009.
[2] Fletcher, J. M.; Vukmanovic-Stejic, M.; Dunne, P. J.; Birch, K. E.; Cook, J. E.;
Jackson, S. E.; Salmon, M.; Rustin, M. H.; Akbar, A. N. Cytomegalovirus-
speciﬁc CD4þ T cells in healthy carriers are continuously driven to replica-
tive exhaustion. J. Immunol. 175:8218–8225; 2005.
[3] Plunkett, F. J.; Franzese, O.; Finney, H. M.; Fletcher, J. M.; Belaramani, L. L.;
Salmon, M.; Dokal, I.; Webster, D.; Lawson, A. D.; Akbar, A. N. The loss of
telomerase activity in highly differentiated CD8þCD28-. J. Immunol.
178:7710–7719; 2007.
[4] Derhovanessian, E.; Larbi, A.; Pawelec, G. Biomarkers of human immunose-
nescence: impact of cytomegalovirus infection. Curr. Opin. Immunol.
21:440–445; 2009.
[5] Harman, D. Origin and evolution of the free radical theory of aging: a brief
personal history, 1954-2009. Biogerontology 10:773–781; 2009.
[6] Le-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A. Protein
carbonylation in human diseases. Trends Mol. Med. 9:169–176; 2003.
[7] Nystrom, T. Role of oxidative carbonylation in protein quality control and
senescence. EMBO J 24:1311–1317; 2005.
[8] Sitte, N.; Huber, M.; Grune, T.; Ladhoff, A.; Doecke, W. D.; von, Z. T.; Davies, K. J.
Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of ﬁbroblasts.
FASEB J 14:1490–1498; 2000.
[9] Hohn, A.; Jung, T.; Grimm, S.; Catalgol, B.; Weber, D.; Grune, T. Lipofuscin
inhibits the proteasome by binding to surface motifs. Free Radic. Biol. Med.
50:585–591; 2011.
[10] Levine, R. L.; Stadtman, E. R. Oxidative modiﬁcation of proteins during aging.
Exp. Gerontol. 36:1495–1502; 2001.
[11] le-Donne, I.; Rossi, R.; Giustarini, D.; Gagliano, N.; Lusini, L.; Milzani, A.; Di, S. P.;
Colombo, R. Actin carbonylation: from a simple marker of protein oxidation
to relevant signs of severe functional impairment. Free Radic. Biol. Med.
31:1075–1083; 2001.
[12] Smerjac, S. M.; Bizzozero, O. A. Cytoskeletal protein carbonylation and
degradation in experimental autoimmune encephalomyelitis. J. Neurochem.
105:763–772; 2008.
[13] Vikhoreva, N. N.; Vikhorev, P. G.; Fedorova, M. A.; Hoffmann, R.; Mansson, A.;
Kuleva, N. V. The in vitro motility assay parameters of actin ﬁlaments from
Mytilus edulis exposed in vivo to copper ions. Arch. Biochem. Biophys.
491:32–38; 2009.
[14] Banan, A.; Zhang, Y.; Losurdo, J.; Keshavarzian, A. Carbonylation and
disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunc-
tion and its prevention by epidermal growth factor and transforming growth
factor alpha in a human colonic cell line. Gut 46:830–837; 2000.
[15] Mirzaei, H.; Regnier, F. Protein:protein aggregation induced by protein
oxidation. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 873:8–14; 2008.
[16] Pollard, T. D.; Cooper, J. A. Actin, a central player in cell shape and movement.
Science 326:1208–1212; 2009.
[17] Jung, T.; Catalgol, B.; Grune, T. The proteasomal system. Mol. Aspects Med.
30:191–296; 2009.
[18] Reinheckel, T.; Sitte, N.; Ullrich, O.; Kuckelkorn, U.; Davies, K. J.; Grune, T.
Comparative resistance of the 20S and 26S proteasome to oxidative stress.
Biochem. J. 335(Pt 3):637–642; 1998.
[19] Grune, T.; Reinheckel, T.; Davies, K. J. Degradation of oxidized proteins in
mammalian cells. FASEB J 11:526–534; 1997.
[20] Shringarpure, R.; Grune, T.; Mehlhase, J.; Davies, K. J. Ubiquitin conjugation is
not required for the degradation of oxidized proteins by proteasome. J. Biol.
Chem. 278:311–318; 2003.
J.P. Castro et al. / Free Radical Biology and Medicine 53 (2012) 916–925 925[21] Lasch, P.; Petras, T.; Ullrich, O.; Backmann, J.; Naumann, D.; Grune, T.
Hydrogen peroxide-induced structural alterations of RNAse A. J. Biol. Chem.
276:9492–9502; 2001.
[22] Sitte, N.; Merker, K.; Grune, T. Proteasome-dependent degradation of oxi-
dized proteins in MRC-5 ﬁbroblasts. FEBS Lett 440:399–402; 1998.
[23] Divald, A.; Powell, S. R. Proteasome mediates removal of proteins oxidized
during myocardial ischemia. Free Radic. Biol. Med. 40:156–164; 2006.
[24] Grune, T.; Jung, T.; Merker, K.; Davies, K. J. Decreased proteolysis caused by
protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggre-
somes’ during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol.
36:2519–2530; 2004.
[25] Weng, N. P. Aging of the immune system: how much can the adaptive
immune system adapt? Immunity 24:495–499; 2006.
[26] Takahashi, A.; Hanson, M. G.; Norell, H. R.; Havelka, A. M.; Kono, K.;
Malmberg, K. J.; Kiessling, R. V. Preferential cell death of CD8þ effector
memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative
stress. J. Immunol. 174:6080–6087; 2005.
[27] Effros, R. B. Telomere/telomerase dynamics within the human immune
system: effect of chronic infection and stress. Exp. Gerontol 46:135–140;
2011.
[28] Grune, T.; Reinheckel, T.; Joshi, M.; Davies, K. J. Proteolysis in cultured liver
epithelial cells during oxidative stress. Role of the multicatalytic proteinase
complex, proteasome. J. Biol. Chem. 270:2344–2351; 1995.
[29] Grune, T.; Reinheckel, T.; Davies, K. J. Degradation of oxidized proteins in K562
human hematopoietic cells by proteasome. J. Biol. Chem. 271:15504–15509;
1996.
[30] Grune, T.; Merker, K.; Jung, T.; Sitte, N.; Davies, K. J. Protein oxidation and
degradation during postmitotic senescence. Free Radic. Biol. Med. 39:1208–1215;
2005.
[31] Jung, T.; Hohn, A.; Catalgol, B.; Grune, T. Age-related differences in oxidative
protein-damage in young and senescent ﬁbroblasts. Arch. Biochem. Biophys.
483:127–135; 2009.
[32] Jung, T.; Bader, N.; Grune, T. Oxidized proteins: intracellular distribution
and recognition by the proteasome. Arch. Biochem. Biophys. 462:231–237; 2007.[33] Johnston, J. A.; Ward, C. L.; Kopito, R. R. Aggresomes: a cellular response to
misfolded proteins. J. Cell Biol. 143:1883–1898; 1998.
[34] Kueper, T.; Grune, T.; Prahl, S.; Lenz, H.; Welge, V.; Biernoth, T.; Vogt, Y.;
Muhr, G. M.; Gaemlich, A.; Jung, T.; Boemke, G.; Elsasser, H. P.; Wittern, K. P.;
Wenck, H.; Stab, F.; Blatt, T. Vimentin is the speciﬁc target in skin glycation.
Structural prerequisites, functional consequences, and role in skin aging.
J. Biol. Chem. 282:23427–23436; 2007.
[35] Vicente-Manzanares, M.; Sanchez-Madrid, F. Role of the cytoskeleton during
leukocyte responses. Nat. Rev. Immunol. 4:110–122; 2004.
[36] Zamir, E.; Geiger, B. Molecular complexity and dynamics of cell-matrix
adhesions. J. Cell Sci. 114:3583–3590; 2001.
[37] Demali, K. A.; Wennerberg, K.; Burridge, K. Integrin signaling to the actin
cytoskeleton. Curr. Opin. Cell Biol. 15:572–582; 2003.
[38] Hwang, I.; Sprent, J. Role of the actin cytoskeleton in T cell absorption and
internalization of ligands from APC. J. Immunol 166:5099–5107; 2001.
[39] Samstag, Y.; Nebl, G. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB
mediated signalling pathways in untransformed human peripheral blood T
lymphocytes. Adv. Enzyme Regul 45:52–62; 2005.
[40] Pollard, T. D. Mechanics of cytokinesis in eukaryotes. Curr. Opin. Cell Biol.
22:50–56; 2010.
[41] Suresh, S. Biomechanics and biophysics of cancer cells. Acta Biomater.
3:413–438; 2007.
[42] Weissmann, C.; Brandt, R. Mechanisms of neurodegenerative diseases:
insights from live cell imaging. J. Neurosci. Res. 86:504–511; 2008.
[43] Das, R.; Ponnappan, S.; Ponnappan, U. Redox regulation of the proteasome in
T lymphocytes during aging. Free Radic. Biol. Med. 42:541–551; 2007.
[44] Ponnappan, U.; Zhong, M.; Trebilcock, G. U. Decreased proteasome-mediated
degradation in T cells from the elderly: a role in immune senescence.
Cell. Immunol. 192:167–174; 1999.
[45] Chondrogianni, N.; Stratford, F. L.; Trougakos, I. P.; Friguet, B.; Rivett, A. J.;
Gonos, E. S. Central role of the proteasome in senescence and survival of
human ﬁbroblasts: induction of a senescence-like phenotype on its inhibition
and resistance to stress on its activation. J. Biol. Chem. 278:28026–28037;
2003.
  
 42 
 
 
 
 
 
 
 
 
 
 
 
 
PUBLICATION II 
Castro, J. P.; Jung, T.; Grune, T.; Almeida, H. Actin carbonylation: From cell 
dysfunction to organism disorder. Journal of Proteomics. Special Issue: 
Posttranslational Protein Modifications in Biology and Medicine. Oct 30;92:171-80. 
Epub 2013 May 15 
 
 
 
 
 
 
 
 
J O U R N A L O F P R O T E O M I C S 9 2 ( 2 0 1 3 ) 1 7 1 – 1 8 0
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
ScienceDirect
www.e l sev i e r . com/ loca te / j p ro tReview
Actin carbonylation: From cell dysfunction to
organism disorder☆José Pedro Castroa, b, c, Tobias Jungc, Tilman Grunec, Henrique Almeidaa, b,⁎
aDepartamento de Biologia Experimental, Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal
bIBMC-Instituto de Biologia Molecular e Celular, 4150-180 Porto, Portugal
cInstitute of Nutrition, Friedrich Schiller Universität Jena, Dornburger Str. 24, 07743 Jena, GermanyA R T I C L E I N F O☆ This article is part of a Special Issue entit
⁎ Corresponding author at: Departamento de
22 042 6744; fax: +351 22 551 3655.
E-mail address: almeidah@med.up.pt (H.
1874-3919/$ – see front matter © 2013 Elsevie
http://dx.doi.org/10.1016/j.jprot.2013.05.006A B S T R A C TAvailable online 15 May 2013 Protein carbonylation is an important event in the context of proteostasis because of its
frequency, non-enzymaticnature and irreversible effects. The carbonylationof proteinsdisturbs
their function and leads to protein aggregates, which may precede cellular senescence and cell
death.
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aggregate formation. In this review, we summarise actin susceptibility to carbonylation, as
verified in cell free extracts, cell lines and animal models, and review its fate through the
activation of cell mechanisms aimed at removing damaged proteins. Their insufficient
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During aerobic metabolism, the transfer of electrons in the
respiratory chain is not entirely efficient because of electron
leakage at Complex I (NADH dehydrogenase) and Complex III
(cytochrome bc1 complex), possibly at variable proportions,
according to specific organs or cells [1] and to the life span of
the considered species [2].
It is estimated that 1–2%of the oxygen used bymitochondria
in vitro [1] is converted into superoxide in thisway. Although this
production in mitochondria seems to be the most important
source of oxidising species, other locations in the cell provide
additional contributions. That is the case of the endoplasmic
reticulum membrane, where cytochrome P450 catalyses the
oxidation of substrates, such as prostaglandins, steroid hor-
mones, drugs and environmental xenobiotics [3]. Furthermore,
other oxygen-metabolising enzymes are known to contribute to
the release of oxidising species, such as xanthine oxidase,
NADPH oxidases, cycloxygenases, lipoxygenases and others [4].
An additional oxidative burden results from the enzymatic
production of nitric oxide (NO) radicals by at least three different
types of NO synthase enzymes [5], autoxidation processes and
thepossibility of rapid reactionsbetweenall these species. Thus,
although the superoxide anion (O2−) is likely the most perma-
nently produced primary reactive oxygen species (ROS), it is also
the precursor of other oxidisingmolecules that contribute to the
whole level of oxidative compounds. When not buffered by
antioxidants, they lead to oxidative stress and disturbing effects
on biomolecules.1. Effects of oxidising species on biomolecules
The effects of the superoxide anion in different cell compart-
ments are restricted by the anion's limited ability to diffuse
across membranes. Moreover, this anion is rapidly scavenged
and dismutated by superoxide dismutases into hydrogen perox-
ide, a non-radical oxidant, which, in contrast with superoxide,
rapidly diffuses within the cell. This is a useful property that
is explored when cells in culture are experimentally challenged
with hydrogen peroxide added to the medium. It is detoxified
by catalases or by peroxidases from a variety of cell compart-
ments but may also be converted into the highly reactive
hydroxyl anion upon its cleavage by transition metal catalysed
reactions, as is the case when Fe++ or Cu+ ions are oxidised. It
appears that under normal conditions,metal catalysed oxidation
is a major source of oxidative damage [6] that is permanently
exerted on such molecules as sugars, nucleic acids, lipids and
proteins.
The large array of products formed from the oxidation of bio-
molecules is dependent on the nature of the damaged biomol-
ecule, the oxidant and the biological environment. Briefly, the
oxidation of polysaccharides results in their depolymerisation or
fragmentation [7], whereas continued oxidation of glycated
proteins promotes the formation of advanced-glycated end
products (AGEs) and the ability to interact with the receptor for
AGEs and enhance the oxidative burden upon nearby molecules
[8]. Also worth consideration is the effect of oxidants on the
sugars of nucleotides that lead to their carbonylation, ability tobind iron and to intensify the Fenton reaction. In addition, ROS
target nucleotide purines and pyrimidines that result in base
deamination, ring openings, adduct formation and whole
nitrogen base loss, which, together with the failure of repairing
mechanisms, allow the establishment of mutations. Lipids are
another class of molecules attacked by ROS, where the carbon–
carbon double bonds of unsaturated fatty acids are an impor-
tant target. The effects may be limited, but in the presence of
oxygen, they may progress to the formation of new peroxyl
radicals that continue oxidative damage on new lipids and
produce more oxidised lipid hydroperoxides.
An important category of biomolecules that are subjected to
the oxidation process are proteins. The effect of free radicals on
them is diverse and relates to the intensity of the challenge, the
actual oxidised amino acids and the type of protein involved [9].
The oxidation may result from the direct interaction with free
radicals or may be indirect, secondary to the action of other
previously oxidised proteins, lipids or sugars [10–12]. The effects
may bemild and reversiblewhen the oxidation is limited to a few
amino acids, for example, when sulphur-containing residues of
cysteine or methionine are oxidised to cysteinyl derivatives or
methionine sulphoxide and benefit from the repairing ability of
specific reductive systems [13]. By contrast, the effects may be
irreversible, for example, when the attack addresses a variety of
amino acid residues with aromatic or long side chains, such as
histidine, tryptophan, tyrosine or phenylalanine [9]; moreover,
the oxidation of other amino acid residues as proline, arginine,
lysine and threonine, results in irreversible carbonyl formation, a
consequence of major importance because of their quantity
[12,14–17].
Protein carbonylation is an indicator of severe or perma-
nent oxidative damage [18], as it occurs in many disorders
that affect cell functioning and survival [6] and following
exposure to oxidants in experimental conditions. In this case,
the assessment of protein oxidation is performed primarily
using commonmethods of carbonylation assay, which is one
reason why carbonylation and oxidation are frequently used
synonymously, as we will do in the rest of this manuscript.
Protein carbonylation assessment is currently simplified by
the development of such techniques as the derivatisation of
carbonyls with 2,4-dinitrophenylhydrazine (DNPH) followed
by immunodetectionwith an anti-DNP antibody in aWestern
blot or ELISA assay or the derivatisation with biotinhydrazide
and detection with fluorescent avidin probes. Frequently,
these procedures are based on 2D gels, which amplify protein
resolution and allow further analysis, such as the quantification
of the oxidation level in relation to the overall protein content, or
the protein identity via mass spectrometry. In specific cases of
protein identification, previous protein enrichment procedures
are necessary. Recently, the 2-iminobiotinylation of carbonylated
peptides or derivatisation with Girard P reagent were proposed
before further proteinquantitationor identification (for adetailed
review of methods, see [19]).
It is generally accepted that the damage of proteins leads
to their abnormal conformation, loss of functional ability,
unfolding and exposure of hydrophobic domains, which mark
them for degradation by the proteasome [20,21]; alternatively,
such domains are the targets for ROS attack and further protein
derangement.Of equal importance, the exposureof hydrophobic,
sticky domains, usually concealed inside the protein structure,
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promotes aggregation, which, via cross-linking, leads to the
establishment of high-molecular-weight aggregates [11,12,18,
22,23]. Additionally, the generationof a Schiff baseby the reaction
of a carbonyl group of one protein with an amino group from
another, e.g., lysine residues, also contributes to the formation of
aggregates and indicates that they are able to grow without
further oxidation reactions [24].
Notably, such aggregates are hard to remove from the
cellular environment and are stored. Independent of their
formation, the majority of these oxidised protein aggregates
are compiled in the lysosomes and are taken up via
macrophagy [25]. However, there is another storage form –
the aggresomal structure –which is aimed at specific proteins
(perhaps cytoskeletal proteins) or is an intermediate storage
form [26–28].
The historical view that those stored proteins are in an
inert final deposit, where they cannot influence the cellular
metabolism, has long been overcome. The aggregates are able
to affect the cellular metabolism and lead to cell death [27,28].
In addition, beyond exhibiting resistance to proteasome
degradation, they disturb the cellular degradative ability of
other proteins [6,29–31] by inhibiting the proteasome [31,32].
Moreover, it is known that because of the presence of various
metals in accumulated protein aggregates [33], these aggre-
gates can produce oxidants in a senescent cell [34]. Further-
more, by variousmechanismsdescribed, suchproteinaggregates
are able to influence gene expression on a transcriptional level
[35,36].2. Actin: a cell-wide dynamic polymer with
active involvement in cell functioning
The discovery of actin was reported by Brunó Straub et al. in
1942 upon its extraction from skeletal muscle cells, where it
occupies a large proportion; later, actin's presence was
verified in many other cells, albeit exhibiting a different
isoform [37]. The protein is not restricted to eukaryotic
cytoplasm because it takes part in nuclear structure and
functioning. In addition, the presence of structurally similar
proteins in bacteria [38] indicates that actin is an ancient cell
protein and an evolutionarily successful one. Thus, it is not
surprising that actin participates in many different and
fundamental cell and tissue functions [39] that range from
mechanical support for cell shape and muscular contraction
to endocytosis, organelle movement, neuronal and immu-
nological synapses and cell movement toward chemical
attractants.
The actin monomer, actin G, is the fundamental actin
structure, whichever isoform is considered. Actin is a 375-
amino-acid protein composed of two main domains separated
by a cleft, where an ATP complexed with Mg++ is bound and
ATPase activity is located. Monomers polymerise after slight
rotational movement of the incoming monomer that eventually
results in an apparent double stranded helical conformation. An
important prerequisite of this process appears to be a hydropho-
bic loop of actin G monomer that interacts with a hydrophobic
pocket located between other actin monomers and stabilises the
filament thereof.The human genome has 6 actin genes that encode 4
muscle (α) and 2 non-muscle (β and γ) actin isoforms; how-
ever, despite this diversity, the protein amino acid sequence
is rather similar among all isoforms, except the amino
terminal [40]. A noteworthy example of the conservation of
actin among eukaryotes is the 88% identity between verte-
brate striated muscle actin and yeast single gene coded actin
[41].3. From cells to organisms— actin carbonylation
as a result of stressful conditions
From in vitro cell-free studies, through cells and organisms,
the verification of actin susceptibility to oxidation has gathered
increased interest in recent years.
In vitro, purified actin is oxidised in away that is dependent on
the concentration of the oxidant andon the timeof exposure [42].
Cysteine 374, at the carboxyl extremity of theα actin (or Cys272 in
β and γ actin) [43] and the yeast actin [44] are notably sensitive to
oxidation because of their localisation at or close to the surface of
the actin molecule; these reactions are followed by oxidation of
methionines 44, 47 and 355 [45]. Actin carbonylation imparts the
enhanced exposure of its hydrophobic regions and narrowing of
the cleft separating the 2 main domains, which leads to the
reduced ability to complexwithATP [45] and to polymerise. Actin
oxidation may be elicited by a variety of different compounds,
such as chloramines [45], acrolein [46], hypochlorite [42], hydro-
gen peroxide [47,48] and others [49–52].
Although several of these studies were addressing actin
changes, others were unexpected observations in different
contexts and fields. In fact, it was shown that the exposure of
different cells or biological samples to oxidative conditions
affects many proteins, of which actin was found to be notably
sensitive, as evidenced by carbonylation assays.
Diet composition, for example, may lead to a variation in
actin carbonylation and nitrotyrosination [53], suggesting the
possibility for its prevention; a point supported by the beneficial
effects of adding oats to the diet [54]. Antioxidants have been
studied intensely because of their hampering effect on prolifer-
ation, although the underlyingmechanismmay differ according
to the compound. For instance, the use of hops antioxidants,
such as proanthocyanidins, resulted in HT29 colon cell line
proliferation arrest [55], an effect attributed to substantial actin
carbonylation and cytoskeleton functional impairment. A sim-
ilar consequence was noted in epithelial Caco-2 cells [56], yeast
cells upon hydrogen peroxide administration [44] and a neuro-
nal cell line after inflammatory cytokine challenge [57].
Animal studies on the effects of other stressors and
environmental agents on carbonylation were also examined
in conditions that emphasised the relevance of cytoskeletal
protein oxidation. For example, α-actin from cod fish muscle
is rather sensitive to ferrous catalysed oxidation [58] and
ferric nitrilotriacetate administration to rats results in increased
oxidised proteins in gastrocnemius muscle [50], whereas the
in vivo contact of mussels with environmental pollutants was
followed by carbonylation enhancement of β-actin in their
muscle cells [59]. In a different setting, the unexpected de-
tection of carbonylated actin in the serumof pigshoused at high
densities [60] was considered a potential stress biomarker.
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tional consequences. For example, whereas mild oxidation of
surface sulphur-containing residues has a limited effect on actin
polymerisation ability, additional oxidation strongly inhibits it
and even enhances its fragmentation [45].
In addition, when oxidative insult is intense and continued,
actin aggregate formation ensues. This was shown in muscle
[42] and non-muscle [48] actin-rich cell-free fractions. Further-
more, in a cell linemodel of hydrogen peroxide oxidative stress
[48], such aggregateswere noticed at 24 h of cell culture, but not
at a shorter, 3 hour stress time, further indicating that beyond
its susceptibility to carbonylate, actin's ability to form aggre-
gates is time-related.
All these data converge with the view that actin is among
the most preeminent proteins oxidised upon cell exposure to
oxidants [43], but the reason for this susceptibility is not
known. One possible reason is the intracellular actin content:
actin constitutes 10% of the whole protein in normal and
leukaemic lymphocytes, approximately 8% and 5%, respec-
tively [61], myeloid leukaemia cells (5%, [62]), adrenocortical
cells (10–12%, [63]) and fibroblasts (7–14%, [64]). Another possible
reason is the actin localisation: it is present throughout the
cytoplasm, off the lumina of membranous compartments,
therefore, it is easily accessible to diffusible oxidative com-
pounds. Additionally, similar to other proteins, actin may have
specific structural features that make it more prone to
oxidation. For example, upon submission of yeasts to H2O2,
only 8% of the whole yeast protein becomes oxidised, but this
oxidation amounts to 80% when ribosomal protein is consid-
ered [65]. By contrast, in Escherichia coli cultures, H2O2 oxidation
targets the protein synthesis factor EF-G [66], and when the
cells are grown in a medium with a methionine substitute
and stressed, the small increase in total carbonyls is
outweighed by remarkable carbonylation of EF-Tu, the most
plentiful protein in that bacteria [67]. Similarly, oxidation of
arthropod mitochondria results in isolated aconitase carbon-
ylation [68].
Wewould add thatmuscle actin extracted and processed for
scientific purposes may spontaneously oxidise [69], and its
storage at usual freezing temperatures may not be sufficient to
prevent its oxidation after some time [70], further emphasising
its susceptibility and the need to employ carefully controlled
conditions.
Actin carbonylation/aggregation and its biological signifi-
cance will be discussed further in the next sections.4. The fate of carbonylated actin: turnover
or aggregation?
The fate of actin inside cells under physiological non-oxidising
conditions remains debatable. For example, what occurs to
G-actin after F-actin depolymerisation and dismantlement? To
the best of our current knowledge, there is no mechanism that
promotes F-actin degradation, only depolymerisation by actin
binding proteins, such as gelsolin [71]. However, evidence from
cultured chick embryonic cardiomyocytes favours a role for
caspase-2 in G-actin degradation by proteolytic cleavage. It was
shown that lovastatin, a drug used to induce the loss of F-actin,
operates in a caspase-2 dependent manner; when a caspase-2inhibitor was employed, no actin degradation was found in this
cell type [72], suggesting an important role for caspase-2 in
non-oxidised actin turnover. There is also evidence from
cultured neonatal rat heart cells that, whenmuscle contraction
was inhibited by pharmacological drugs, α-actin was partially
degraded by the lysosome, pointing to a differentmechanismof
degradation [73]. Recently, actin degradation has been linked to
an E3 ubiquitin ligase motif-containing 32 (TRIM32), which
binds myosin in skeletal muscle and ubiquitinates α-actin in
vitro. The overexpression of TRIM32 in human embryonic
kidney cells leads to a decrease in cytoplasmic actin, supporting
the involvement ofTRIM32 [74]. Thus, non-oxidised actin seems
to be degraded by differentmechanisms, thereforemaintaining
the debate of how it is actually degraded — an open question
that needs further investigation.
Under non-physiological oxidative environments, cells have
to cope with damaged proteins and prevent their accumulation;
for that purpose, they use degrading systems, such as the
proteasome. Althoughmildly oxidised proteins are an attractive
substrate for proteasomal degradation [10,21,75,76], in condi-
tions of ROS burst from environmental or intracellular sources,
proteasome function is compromised or insufficient [77], and
proteins tend to accumulate asnon-degradable, insoluble aggre-
gates that additionally contribute to proteasome inhibition
[31,32]. In time, cells may attain the growth arrest condition
and even die by apoptosis [22,34,78], with consequent tissue
damage and dysfunction.
The proteasome, the most important non-lysosomal mecha-
nism for protein turnover in cells [79], is a complex catalytic
feature that exhibits two predominant forms, the 20S catalytic
core, which is ATP and ubiquitin tagging independent, and the
26S form that combines the 20S core and at least one 19S
regulatory cap, involved in the recognition of ubiquitinated
substrates, which is, therefore, ATP and ubiquitin dependent.
Extensive and detailed description of the structure and regula-
tion of the proteasome is reviewed elsewhere [79].
The 20S proteasome form has been shown to be the main
site for oxidised protein degradation [10,75,76,79–82], and
there are at least three reasons for its preeminent involve-
ment. First, the 20S proteasome itself is relatively resistant to
oxidative stress [83]; second, oxidised proteins expose hydro-
phobic residues that under stressful conditions can act as a
trigger for degradation, independently of ATP and ubiquitin
tagging [20,21]; third, because lysine residues are preferential
targets of oxidative modification, ubiquitin lysines would be
less able to bind to substrates, therefore, could impair the
whole process [10,79,84,85]. Thus, despite the large number of
studies favouring the 20S proteasome role in degrading mildly
oxidised proteins [10,21,79], when oxidation is too extensive,
protein aggregates can form and even inhibit the proteasome
[14,31,32].
The 26S proteasome generally requires the preceding action
of the ubiquitin system, consisting of three types of enzymes: E1
ubiquitinactivating enzymes, E2ubiquitin conjugatingenzymes
and E3 ubiquitin ligases. Ubiquitination is a highly ordered and
specific mechanism, and because of the diversity of existing
enzymes, ubiquitination can form countless possibilities of
arrangements. The process starts when the E1 enzymes bind
one ubiquitin molecule to its C-terminal glycine, then ubiquitin
is transferred to E2 enzymes. The last step of the chain is
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finally, depending on E3 enzyme type, ubiquitin is either tagged
directly to lysine residues in the substrate or indirectly in a
two-step mechanism (for detailed process description, see [79]).
Conversely, it was shown that proteasome inhibition in-
creases the steady state amount of carbonylatedproteins. In the
post-ischaemic rat heart, oxidised actin, but not actin ubiquitin
adducts, were found, suggesting a 20S proteasome-mediated
proteolysis [86,87]. In support, we and the Davies group
demonstrated that the disruption of the ubiquitin tag system
by compromising ubiquitin conjugating activity did not impair
the degradation of oxidised proteins [84]. Early on, cysteine and
methionine were described as prone to oxidative stress,
therefore, it is noteworthymentioning that thesemodifications,
particularly the Cys374 residue of actin, contribute to a decrease
in actin susceptibility to α-chymotrypsin and subtilisin prote-
olysis, by changing the structure of the subdomain 2 in the actin
molecule [88,89]. This could allow the formation of insoluble
highmolecular weight actin carbonylated aggregates. In fact, in
hydrogen peroxide treated cells, we showed that carbonylated
actin is partially degraded by the proteasome [48]. After
inhibiting the proteasome with lactacystin in stress conditions,
an increase of carbonylated actin and highmolecular aggregate
formation and accumulation were detected, thus pointing to
the proteasome's ability to degrade moderate actin carbonyla-
tion; however, progressive impairment in a continuous oxida-
tive environment and after the formation of actin aggregates
was also observed. The binding of aggregates to the proteasome
was shown by immunofluorescence co-localization studies of
actin aggregates and the β5 proteasome subunit. These studies
favour two possible fates of oxidised actin, depending on the
duration of oxidative stress and proteasome functionality.
Aggregate formation is, therefore, a likely scenario that can
alter cellular metabolism and contribute to cell and tissue
dysfunction (Fig. 1).5. Actin carbonylation involvement in
cytoskeleton disturbance, cell dysfunction and
age-related diseases
External conditions, suchas ionising radiation and atmospheric
chemicals, may exert acute or chronic oxidative stress on cells
or organisms that results in functional abnormalities. Similar
consequences are observed in the persistent effects of internal
disorders that include inflammatory reactions, chronic degen-
erative diseases or the simple living process throughout the
organism's lifespan.
Ageing, particularly the last third of life, is associated with
an enhancement of protein carbonyl content [90–94]; indeed,
the continued effect of ROS on cells and tissues was pro-
posed as a cause of the ageing process itself [95]. Because
ROS are produced as long as cells and organisms are alive,
the consequences are continuous and progressive. Not un-
expectedly, the outcome is the reduced functional ability of
cells or tissues, ill adaptation to stressful conditions and
clinical findings of overt disease. In a variety of human
disorders, a 2–3-fold increase in oxidised protein content was
estimated, resulting in a level of up to one carbonylated protein
in every 3 present [6].A target protein that is part of this generalised age-related
carbonylation is actin. Among others, actin carbonylation was
found to be enhanced in the aged brain of mice [96], which was
prevented by lipid peroxide scavengers in specific experimental
conditions [97]. Despite the scarcity of data in this respect, such
observations suggest that the carbonylation of proteins, such as
actin, is included in the ageing process, and its prevention could
be an approach to relieving the ageing phenotype.
Notably, the carbonyl content increases in a variety of
tissues or cells, and its targeting of actin was shown in human
disorders with cytoskeleton functional impairment, such as
Alzheimer disease (AD). In necropsies of selected brain areas of
AD patients, extracellular deposition of Aβ amyloid protein,
intracellular fibrillary tangle accumulation and neuronal cell
loss were described [98]. The tangle stem from intracellular
aggregates of tau protein that normally promote microtubule
stabilisation; in AD however, tau hyperphosphorylates, loses
microtubule interaction and aggregates in abnormal helical
polymers [98]. Furthermore, there is mechanistic evidence that
Aβ and tau protein aggregates interfere with cellular protein
turnover [32,99–101] and interact with actin, resulting in actin
aggregation, which is hypothesised as the feature underlying
cell loss in AD [102].
There is considerable evidence in favour of oxidative stress
intervention in the pathogenesis of AD and other human
degenerative disorders [103]. Indeed, the increase in protein
oxidation is an important finding in the hippocampus and
inferior parietal lobule of AD patients [104]; in addition, there
is compelling evidence for increased carbonylated β-actin in
AD-affected brain regions [105]. Moreover, protein oxidation
increase was also verified in post-mortem exams of the brains
from humans that were classified as having mild cognitive
impairment [106], which provided additional support for actin
carbonylation involvement in the pathogenesis of AD.
Similarly, enhanced actin carbonylationwas found in human
heart failure [107,108], in a fashion that correlated with organ
dysfunction.
In the experimental conditions of an ischaemia–reperfusion
injurymodel, the reperfusion of a previously ischaemic tissue is
accompanied by a burst of inflammatory mediators and ROS
production. Notably, the microglia of the hippocampus from
reperfused monkey brains exhibited selective actin and HSP70
protein carbonylation [109], as did ischaemic rat heart muscle
reperfused ex vivo upon previous ischaemia, in an apparent
time-dependent fashion [47,86]. There is evidence that these
processes result in strongactin carbonylation of up to 7-fold [47],
and several findings also suggest that this might be suppressed
by antioxidants [110].
Similar selective effects on actin were noticed in rat
diaphragm muscles, following a systemic inflammatory state
mimicked by LPS injection [111], and in the spinal cord of an
experimental model of autoimmune encephalomyelitis [112].
Moreover, a model to study inflammation, employing macro-
phage cultures in excess of oxygen, also evidenced enhanced
actin carbonylation togetherwith actin depolymerisation in the
cell periphery and its polymerisation deep in the cytoplasm
[113].
Carbonylation of actin also occurs in malignant transforma-
tions, as was recently observed in human cervical cells from
dysplastic lesions causedby thehumanpapillomavirus infection
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Fig. 1 – Fate of carbonylated actin and biological implications.When the cellular internal redox state changes because of enhanced
ROS production, mainly bymitochondria, proteins become carbonylated. Actin (in blue), has a high susceptibility to this oxidative
modification and undergoes functional impairment along three main proposed stages that range frommild protein oxidation to
aggregation. In the first stage, actin is carbonylated (carbonyl groups in red), though it partially maintains its function; as
stress persists, it becomes more oxidised, unfolds, exposes hydrophobic domains (in orange) and loses its function. At the
third stage, upon further oxidation and/or proteasome inhibition, hydrophobic domains favour binding and aggregation with other
carbonylatedproteins.Althoughabundant in cells andengaged inmany important activities, actin susceptibility to carbonylationand
to form aggregates relates to cellular dysfunction. In fact, that was noticed inmany conditions that include age-related degenerative
disorders and chronic inflammation.
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cancer treatment. For example, acrolein, an oncogenic agent and
a metabolite of cyclophosphamide was found to cause the
aggregation of F-actin in rat Sertoli cells [46]. In addition, photo-
dynamic therapy, a technique that is receiving greater atten-
tion and wider application in the field of superficial cancer in
recent times [115–117], was found to cause actin carbonylation
when experimentally applied to a cell line of bladder cancer
[118].6. Conclusions and prospects
Fromanevolutionaryperspective, actin becamean indispensable
protein to cells and organisms because of its involvement in
important biological activities.
Although the actin network is robust, it is also sensitive to
derangements caused by daily living processes. One of these
processes is the continuousproductionof reactive oxygenspecies
that takes place mostly in mitochondria during aerobic metabo-
lism. Amajor effect of ROSproduction is protein oxidation,which
may range from simple reversible effects to irreversible conse-
quences that include protein unfolding and carbonylation. This
process, the best characterised protein oxidative modification, is
non-enzymatic and irreversible and, depending on the type ofstress, duration, and sort of protein involved, leads to protein loss
of function, additional severe oxidation and the formationofhigh
molecular weight oxidised aggregates. Per se, these may induce
changes in cellular metabolism, such as inhibition of protein
turnover by the proteasome, cell cycle arrest and even cell death
by apoptosis.
Actin is organised in such a way that some of its amino
acids are rather sensitive targets to oxidation. By contrast to
the irreversibility of carbonylation, one may speculate that
under milder oxidation, the localisation and susceptibility of
some cysteine and methionine residues sense, buffer and
revert the oxidation; in this case, the cell skeletonwouldwork in
a way that parallels the body skeleton when it buffers organism
acidosis in the long term.However, actin intervention likely goes
beyond that process. In fact, actin appears to promote mito-
chondrial integrity by preventing ROS release [119], and, during
cytoskeleton organisation, it is glutathionylated at Cys374, in a
process where ROS act as second messengers [120]; notably,
actin was found as a largely glutathionylated protein under
oxidative conditions [52].
Therefore, the mainly structural roles of actin may extend
into sensor and regulatory post-translational properties. The
refinement of methods employed in the assessment of actin
molecule structural features may still uncover unexpected
abilities.
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biological processes, actin is now an attractive molecule for the
comprehension of humandegenerative disorders andhealth as a
whole, including the ageing process itself, the quality of food,
heart disease, Alzheimer disease, sustained inflammatory con-
ditions, carcinogenesis and cancer management. The recently
enhanced interest for this widely present and evolutionarily
conserved protein envisages exciting new knowledge in the near
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INTRODUCTION –PART II 
In order to approach the mechanism whereby oxidized actin was conveyed to the 
proteasome, it was hypothesized that a transporter with the ability to bind actin and the 
20S proteasome was the likely molecule. For this purpose, the proteostasis assuring 
Hsp90 chaperone appeared to adapt well. 
1. Hsp90 – A role in assisting oxidized proteins degradation? 
Protein structure is determined by its amino acid composition and the laws of 
thermodynamics; however, the macromolecular overcrowded cytosol can promote 
protein misfolding and aggregation in low stability proteins [106]. To cope with 
unfavorable consequences, cells evolved to synthesize proteins whose role is to assist 
and stabilize other proteins in a constitutively manner. They are usually referred as 
molecular chaperones [107] and most of them belong to heat shock proteins (Hsp) 
family. Under heat or oxidative stress, they are induced [108, 109] to quickly establish 
proteostasis. 
Molecular chaperones as Hsp90 are ATP-dependent and are co-regulated by co-
chaperones that define its final function [106, 110, 111]. Co-chaperones can regulate 
Hsp90 activity and cycle by stimulating or inhibiting ATP hydrolysis, by recruiting 
specific client proteins, by coordinating the interplay with other chaperones as Hsp70 or 
even by their enzymatic activities [106]. 
Hsp90 is highly abundant [106] and has been considered to have a major role in 
stabilizing a diversity of client proteins as kinases, nuclear hormones, receptors, cell 
surface receptors, or transcription factors in the cytosol [112]. Actin has also been show 
to be a client protein of Hsp90 [113-118]. 
The Hsp90 chaperone is a dynamic homodimer. Each monomer can be divided in three 
main domains, the N-terminal, the middle and the C-terminal domains. The C-terminal 
is responsible for dimerization and co-chaperone binding, the middle domain is 
responsible for substrate binding, whereas the N-terminal role is to hydrolyse ATP 
[106]. In a rest state, N-terminal is bond to ADP instead of ATP (Figure 4). 
Hsp90 has a role in stabilizing proteins, but in oxidatively challenged cells, it appears to 
exert additional actions. It can protect the proteasome from oxidative inactivation [119, 
120] and enhance oxidized proteins degradation [121]. Thus, a likely scenario, if Hsp90 
contribution is lost during oxidative stress, degradation of oxidized proteins would 
diminished and accumulate in the form of insoluble protein aggregates. In turn, protein 
aggregates would contribute to further proteasome inhibition.  
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Figure 4. The molecular chaperone Heat Shock Protein 90. (A) The Hsp90 monomer is composed of 
three main domains; N-terminal for ATP hydrolysis, Middle domain for substrate binding and C-terminal 
for dimerization and co-chaperone binding. (B) Hsp90 cycle. The open conformation (bottom) refers to 
Hsp90 dimer rest state with no substrate but with ADP to the N-terminal. When Hsp90 binds a substrate, 
it adopts a closed conformation in order to refold, stabilize or send forward its client protein (top). At this 
point of the cycle, ADP is replaced by ATP, which is later hydrolyzed, which complete the cycle. 
 
 
2. Crosstalk between proteasome and lysosomal autophagy 
Besides the proteasome, the other main site for protein and organelle turnover is the 
lysosome. Proposed by Christian de Duve [122], the lysosome has an important role in 
cellular homeostasis. Due to lysosomal richness in hydrolases, it destroys and clears 
extraneous material and cellular short lived proteins, damaged organelles or even larger 
aggregates. In the past, this process, autophagy, was thought to be unselective but it is 
now recognized to be specific. Autophagy is divided in three types, chaperone-mediated 
autophagy, a type of protein transport due to recognition by molecular chaperone Hsp70 
which fuses with LAMP-2, a lysosomal membrane protein, in the lysosome [123, 124]; 
microautophagy, described as a primary engulfment of small amounts of cytoplasm into 
lysosomes [125]; and macroautophagy, which is responsible for clearance of damaged 
organelles and protein aggregates through the formation and extension of a membrane 
that envelops the substrate and later fuses with the lysosomes [126]. Because protein 
aggregates are related to macroautophagy special emphasis will be given to it.  
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Macroautophagy, hereafter referred as autophagy, starts with a double membrane 
feature that expands and engulfs target organelles or protein aggregates before making 
them available for lysosome digestion. The characterization of the original membrane 
has received a considerable attention lately. It may result from de novo synthesis, but 
may also be originated from the ER, the mitochondria or the plasma membrane [127-
129]; the exact source remains elusive. Current knowledge indicates that the process is 
regulated by about 30 genes, collectively designated as ATG (AuTophaGy) related 
genes. The ultimate aim of the process is to fuse with lysosomes, taking advantage on 
their enzyme rich content, and when fusion is achieved, the features are now called 
autolysosomes, to promote content degradation. 
Briefly, in mammalian cells, when the signaling protein TOR (target of rapamycin) is 
inhibited due to starvation or oxidative stress. The beclin 1-class III PI3K 
(phosphoinositide 3-kinase) protein is required to form the pre-autophagosomal 
structure which is the putative site for autophagosome formation. Afterwards, Atg13, an 
essential autophagy factor, is dephosphosporylated, which allows its association with 
and activation of Atg1 homologues (ULK; uncoordinated family member-51-like-
kinase). This two-protein complex is recruited by FIP200 (Focal adhesion family-
interacting of 200 kDa) to form a new ULK-Atg13-FIP200 complex that will promote 
membrane elongation and complete the autophagosome structure and the encircling of 
the target. At the same time, the membrane is enriched in LC3-II (Light chain), the 
lipidated form of LC3-I. This is an ubiquitin like-protein that undergoes post-
translational modification by ubiquitin-like reactions that culminate in the addition of a 
phosphatidylethanolamine (PE) to LC3-I. This conjugation process is critical in the 
autophagosome expansion process. 
But how are protein aggregates or damaged organelles recognized directed to 
phagosomes in the first place? It is thought to involve ubiquitin and a p62/SQSTM1 
adaptor protein. However, instead of ubiquitinating the protein at lysine 48, as occurs 
before directing substrates to the proteasome, it is made through lysine 63; in addition, 
it recruits p62 and the complex is forwarded to LC3-II enriched autophagosome 
membrane. Later, the autophagosome is completed in a process mediated by Rab7, a 
small GTPase, and LAMP-2. The structure then fuses with lysosomes providing direct 
contact with hydrolytic enzymes and with the substrate for destruction [6]. Together 
with proteasome mediated degradation, macroautophagy is a decisive turnover 
mechanism for clearing protein aggregates or damaged organelles. Not unexpectedly, in 
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recent years a cross-talk between the proteasome and lysosomal autophagy has been 
described, that conduces to autophagy upregulation when the proteasome gets inhibited. 
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ABSTRACT 
To remove mildly oxidized proteins, cells employ the 20S form of the proteasome. 
However, if the rate of protein clearance is inferior to its formation, as occurs under 
oxidative stress (OS) additional oxidation results in non-enzymatic, irreversible, protein 
carbonylation and functional loss, and the promotion of protein aggregates formation 
and accumulation. In Jurkat cells, upon stressful conditions, there is oxidized actin 
aggregates accumulation, impaired proliferation and reduced proteasome activity, 
conditions frequently observed in cell senescence. As Hsp90 is a molecular chaperone 
that assists oxidized proteins degradation and protects the proteasome from oxidative 
inactivation, it was hypothesized that oxidation would prevent its role as actin 
chaperone. 
The study shows that Hsp90 is cleaved into a 73KDa form, the Hsp90c, by a non-
enzymatic, time-related, iron and stress intensity dependent process. It reveals that 
cleavage appears early, progressively increases in the insoluble cytoplasmic fraction and 
later co-localizes with the actin aggregates. In addition, it demonstrates that 
autophagocytosis is activated along the time, as evidenced by LC3-II protein increase in 
cellular extracts. 
These data thus indicate that Hsp90 has an actin chaperoning role and probably directs 
its oxidized form for destruction in the proteasome. In addition, the study provides 
evidence for a dual intervention of cell clearing processes, possibly compensatory, 
because when proteasome activity is reduced, phagocytosis is activated likely as a cell 
survival mechanism. 
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INTRODUCTION  
The functional disability associated to 
ageing has been attributed to random, 
molecular dysfunction and errors, that 
accumulate in cells and tissues [1, 2]. 
While the underlying cause is debated, 
there is evidence favoring the processes 
of continued biological oxidation that, 
through the generation of by-products 
as reactive oxygen species (ROS), 
impinge on biomolecules, including 
proteins.  
An important consequence is protein 
carbonylation, a non-enzymatic 
chemical change that is frequently 
observed in aged cells and tissues [3]  
and results in an irreversible protein 
structural modification and functional 
loss [4].  
Mildly carbonylated soluble proteins are 
recycled at the proteasome. This 
multicatalytic feature assembles mainly 
in two forms, the ATP and ubiquitin 
independent 20S proteasome and the 
ATP and ubiquitin dependent 26S 
proteasome. Both have in common a 
cylinder shaped structure resulting from 
the apposition of αββα protein rings 
containing specific subunits; as the 
catalytic activity is exerted by some of 
the β subunits, the side positioning of α 
subunits limits the catalytic area 
exposure to hazards. While both forms 
of the proteasome are able to destroy 
and recycle proteins, it is the 20S 
proteasome that has been shown to be 
the main destination of oxidized or 
otherwise damaged proteins [5-11]; in 
turn, the 26S proteasome is able to 
degrade naturally folded and even 
functional proteins, when they are 
ubiquitin tagged [12].  
As long as the proteasome clears 
oxidized proteins from the cytoplasm, 
their accumulation is prevented; 
eventually, as oxidation continues, 
proteasome capacity is exceeded, 
protein destruction decreases and 
further oxidation is fostered. This event 
promotes protein unfolding, 
hydrophobic residues exposure and the 
establishment of oxidized protein cross-
links that result in insoluble, high 
molecular weight aggregates that 
directly impair the ubiquitin-proteasome 
system [13], disturb cell functioning, 
and may cause cell senescence or 
apoptosis [14-16]. Protein aggregate 
accumulation thus reflects cellular 
proteostasis impairment and proteasome 
dysfunction; ultimately, it accompanies 
the ageing process and conduces to 
organism disorder [17].  
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The mechanisms whereby oxidized 
proteins are delivered to the proteasome 
have remained elusive, but its 
elucidation would be of utmost 
importance for the understanding of cell 
functioning under stresses. It is 
reasonable to admit that there is a 
transporter having a strong interaction 
with the oxidized protein and the 20S 
proteasome, their major destruction site. 
Such a process was described for the 
cytosolic protein calmodulin that, when 
oxidized by hydrogen peroxide, is 
delivered for destruction at the 20S 
proteasome in a selective interaction 
with the heat shock protein 90 (Hsp90) 
chaperone [18].  
Hsp90 functions as a homodimer, 
whose monomers are composed of three 
distinct domains. The N-terminal 
domain promotes ATP hydrolysis 
required for chaperone substrate 
remodeling, the middle domain has a 
role in substrate binding and the C-
terminal interacts with the other Hsp90 
monomer and binds co-chaperones by 
the use of a TRP binding segment [19]. 
As a chaperone, Hsp90 assists a large 
number of native (client) proteins, 
mostly transcription factors and kinases, 
to fold properly into their functional 
conformation [19]. In addition, Hsp90 
interacts with pre-folded, configured 
proteins to assist them in stabilization of 
ligand binding regions, which 
frequently exibit hydrophilic charged 
surfaces, next to hydrophobic clefts 
[20]. Not surprisingly, Hsp90 inhibition 
is followed by client protein unfolding 
and ubiquitin tagging for destruction 
[19].  
Interestingly, Hsp90 also interacts with 
the 20S proteasome, as reflected in the 
unusual difficulty in separating them 
[21]. In particular, Hsp90 binds to the 
proteasome alfa subunits [22] that, in 
the setting of oxidation, assist client 
protein degradation by the proteasome 
[18]. Moreover, such alfa subunit 
interaction appears to afford protection 
to the deeply located beta type, catalytic 
subunits; in fact, Hsp90 silencing in 
conditions of metal catalyzed oxidation, 
results in proteasome marked functional 
decrement and even inactivation [23, 
24].  
In a previous study, it was verified that 
submitting a T cell line to hydrogen 
peroxide mediated oxidative stress 
resulted in proteasome inhibition, 
oxidized protein aggregates formation 
and cell proliferation arrest [25], 
characteristic features of aged and 
senescent T cells in vivo [26, 27] and in 
vitro [28]. Furthermore, at the same 
conditions, actin was found as most 
susceptible to oxidation and prone to 
aggregate formation [25]. However, 
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while actin containing aggregates were 
shown at 24h upon stress, they were not 
demonstrated at an earlier time, when a 
smaller decrement in proteasome 
functioning was already evidenced.  
Those findings led us to hypothesize 
that, similarly to calmodulin, Hsp90 
interacted with oxidized actin. Indeed, 
in a lymphocyte cell line [29] and 
skeletal muscle extracts [30], Hsp90 
was found to bind actin, to establish 
crosslinks with its filaments [29] and to 
promote bundle formation [19]. In 
contrast, HSP90 inhibition was found to 
reduce actin polymerization [31] further 
emphasizing HSP90 importance in actin 
role. As actin has been considered a 
client protein of Hsp90 chaperone [29-
35], it is possible that a peculiar 
hydrophobic cleft with relevance for 
actin filament growth [36] is the 
structural feature that provides support 
for HSP90 interaction. 
However, in the setting of oxidation, as 
proteasome impairment appears early 
and aggregates are evidenced later, this 
shift in cells under a proliferative arrest 
suggests that additional mechanisms 
would be involved. In fact, to cope with 
redox imbalance and promote 
proteostasis, it has been proposed that 
challenged cells make use of 
mechanisms that lead to protein fold, 
hold or degradation [37]; when 
degradation is activated, the first line is 
proteasome intervention but if protein 
changes are too marked, as when they 
carbonylate or aggregate or the 
proteasome is inhibited, it is the 
autophagy-lysosome system that is 
called to compensate [37, 38]. 
So, on account of the time-related 
proteasome inhibition and actin 
aggregate formation, Hsp90 
involvement in actin fate following 
oxidative stress challenge was further 
explored, hypothesizing that in time, 
20S proteasome inhibition might give 
way to autophagocytosis. 
 
MATERIAL AND METHODS 
Cell culture conditions 
Jurkat cells were cultured in a medium 
containing RPMI 1640, with 10% FBS, 
1% L-glutamine, 1% 
Penicillin/Streptomycin (Biochrom) at 
37
o
C, 5% CO2 in a NUAIRE
TM
 US 
Autoflow CO2 water-jacketed were 
submitted to oxidation by adding 100 
μM hydrogen peroxide (H2O2, Sigma) 
for 3h, 6h, 9h and 24h and comparing to 
0h time-point. When employed, 500µM 
Desferoxamine (DFO, Novartis) was 
used 18h before exposure. 
 
Immunoblotting 
For each experiment or time point, 
Jurkat cells were lysed in 0,1% 
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TritonX-100, 20mM NaCl, 30mM Tris 
pH 7,4, 1mM EDTA and 100mM DTT 
(Lysis Buffer, LB), collected, briefly 
sonicated and protein quantified by the 
Bradford method [39]. A total of 10 µg 
of protein was heated at 65°C for 30 
minutes and samples were loaded and 
resolved in a 10-12% SDS-PAGE gel. 
Proteins were blotted onto nitrocellulose 
membranes (BioRad) and stained with 
Ponceau S for protein loading control. 
Next, membranes were blocked with 
5% BSA/TBST (Tris Buffer Saline with 
Tween 20, 0.1%) for 1h. When the 
experiment was designed to detect 
protein carbonylation, membranes were 
directly derivatized with 2,4-
dinitrophenylhydrazine (DNPH, Sigma 
Aldrich). Briefly, after the transfer, 
membranes were equilibrated in TBS 
(Tris Buffer Saline)/20% Methanol, 
washed for 5 min in 10% 
Trifluoroacetic acid (TFA, VWR), 
incubated for 10 min with 5 mM 
DNPH/TFA (10%) in the dark, washed 
with TFA (10%) to remove DNPH 
excess and washed again five times (5 
min each) with 50% methanol. They 
were then blocked with 5% BSA/TBST 
(Tris Buffer Saline with Tween 20, 
0.1%) for 1h.  
After blocking, the membranes were 
probed with rabbit anti-Hsp90 full 
length (Abcam), and goat anti-actin 
(Santa Cruz), rabbit IgG anti-DNP 
(Sigma) at dilutions of 1:7500, at a 
1:10000, 1:5000 as the primary 
antibodies respectively, rabbit anti-LC3 
(Novus Biological) at a 1:2500 dilution 
and rabbit anti-LAMP-1 at 1:2500 
(Abcam), mouse anti-Hsp90 N-terminal 
at 1:1000 (Abcam). For secondary 
antibodies, IRDye 800CW or IRDye 
680LT were used at 1:15000 dilution, 
depending on primary antibody. They 
were purchased from Li-Cor Odyssey. 
The detection was performed at 
infrared, using the Li-Cor equipment 
from Odyssey. Band intensities were 
quantified by densitometry using 
Odyssey software. Graphics were made 
using GraphPad Prism 5 software. 
 
Immunocytochemistry 
Cells were grown on 6-well plates for 
24h, and after washing in PBS, they 
were placed in poly-L-Lysine slides 
(Jurkat are suspension cells) and 
allowed to dry in the incubator 
described above (see Cell culture 
conditions). Immediately after, they 
were fixed in 4% PFA (Para-
formaldehyde), washed with PBS, 
PBST (Phosphate Buffer Saline with 
Tween 20 0.1%) and PBSTx (Phosphate 
Buffer Saline with Triton X 0,1%) 0,1% 
and incubated for one hour in 
PBST/BSA 2%, to lower unspecific 
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background signal. Then, they were 
incubated overnight at 4°C in a solution 
containing the diluted primary 
antibodies: 1:250 of goat anti-β-actin 
(Santa Cruz, USA), 1:200 for Rabbit 
anti-LC3 (Novus Biologicals), 1:200 of 
rabbit anti-Hsp90 (full length) and 
1:100 of Rabbit ant-LAMP-1 from 
Abcam. After washed twice in PBST, 
cells were incubated with the secondary 
antibodies conjugated with Alexa 
fluorochromes from Molecular Probes, 
donkey anti-goat secondary antibody 
conjugated with Alexa 488 and 568 
(1:1000 prepared in PBST with 2% 
BSA) and with anti-rabbit secondary 
antibody conjugated with Alexa 488 
and 568 (1:1000 prepared in PBST with 
2% BSA) and donkey anti-mouse 
secondary antibody conjugated with 
Alexa 568 (Molecular Probes) 1:1000 
prepared in PBST with 2% BSA). For 
aggregate detection and co-localization, 
a marker dye (Aggresome Detection 
Kit, Enzo Life Sciences) was prepared 
according to the manufacturer protocol. 
Fluorescence samples were analysed on 
a fluorescence microscope Zeiss 
AxioImager Z1 in Porto, Portugal and, 
in a Confocal Microscope Zeiss LSM 
510 with help from Dr. S. 
Monajembaschi, Fritz Lippman 
Institute, Jena. 
 
Cellular fractioning 
After several time-points control cells 
and 100 μM H2O2 treated cells were 
lysed in LB, and centrifuged at 21,100g 
for 35min 4ºC to separate soluble 
fraction (SF) from insoluble fraction 
(IF). Supernatants (SF) were collected, 
and pellets (IF) were resuspended in 
resolubilization buffer (7M Urea, 2M 
thiourea, 4% CHAPS and 100mM DTT, 
RB), adapting a previously described 
procedure [40]. 
 
In vitro Hps90 cleavage 
In a tube, 0,6 µg recombinant human 
Hsp90β (Enzo Life Sciences, ADI-SPP-
777) was subjected to 0,2mM H2O2, 
0,2mMADP and 0,5mM FeCl3 for 1h at 
25ºC, with mild agitation. The reaction 
was stopped adding Catalase. DTT was 
added to the tube, and the sample was 
loaded for SDS-PAGE, followed by 
immunoblot detection against Hsp90, as 
described above. 
 
Proteasomal degradation of oxidized 
actin 
Non-muscle actin (Cytoskeleton Inc.) 
was diluted 1:2 with General Actin 
Buffer (GAB) (Cytoskeleton Inc.), 
supplemented with 5 % Sucrose, 1 % 
Dextrose and 0.2 mM ATP, and 
incubated for 1 h at 4°C. Actin 
oxidation was accomplished incubating 
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20µg actin in 0.1 mM H2O2 for 2 h at 
25°C. Controls (non-oxidized Actin and 
Hsp90β) were incubated solely with 
GAB. The reaction was stopped using 
40 µg/ml catalase and 50 mM DTT. To 
the mixture, 1 µg of isolated 20S 
proteasome [41], and 2 µg of 
recombinant human Hsp90β (Enzo Life 
Sciences, ADI-SPP-777) were added, 
incubated for 2 h at 37°C and later 
centrifuged for 10 min at 3000 g. To 
125 µl of supernatant and 625 µl of 1 M 
HEPES, fluorescamine (Sigma Aldrich, 
47614) solution was added for a final 
concentration of 0.03 % and incubated 
for 5 min. Fluorescamine reacts with 
primary amines, leading to the 
formation of a fluorescent product 
measured at 390 nm excitation/475 nm 
emission wavelength. A series of 
dilutions of glycine (from 0.05 to 
10mM) were used as standard. 
Proteolysis rate was calculated as the 
difference between proteasome and 
blank samples (without addition of 
isolated 20S proteasome).  
 
RESULTS 
Hsp90 accumulates in protein 
aggregates upon oxidative stress and 
associates with actin  
In Jurkat cells submitted to a 24h 
hydrogen peroxide mediated oxidative 
stress, a decrement in proteasome 
activity and the accumulation of 
cytoplasmatic aggregates containing 
carbonylated actin was reported [25]. 
As these findings commonly 
accompany the increase in protein 
unfolding or misfolding and proteostasis 
impairment [42-44], it was reasoned 
that oxidized actin accumulation was 
consequent to reduced proteasome 
ability and abnormal actin interaction 
with Hsp90. Therefore, it was decided 
to verify whether this chaperone was 
somehow involved in actin aggregates 
formation and fate. 
At 24h upon stress, when protein 
aggregates are well established [25], 
Hsp90 full-length antibody detecting 
protein and the aggregate dye co-
localize at coarse areas in the 
cytoplasm, in contrast to 0h (Fig 1A). In 
addition, Hsp90 co-localizes with actin 
(Figure 1B); in fact, while at 0h stress a 
uniform cytoplasmic display of Hsp90 
and peripheral concentration of actin 
was noticed as previously [25], after 
24h of stress, Hsp90 labeling was 
evidenced as condensed masses, with a 
distribution that co-localized to actin 
aggregates (Figure 1B, bottom). 
 
Hsp90 is cleaved after oxidative stress 
into a 73kDa fragment in an iron 
dependent process 
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Because we were interested in the 
interaction between Hsp90 and oxidized 
actin, that would promote actin 
degradation, it was expected that if 
Hsp90 became less functional, oxidized 
actin degradation would be impaired, 
contributing to protein aggregates 
formation. It is known that oxidative 
stressful conditions promote Hsp90 
cleavage. In fact, there was a notorious 
decrease in Hsp90 level at 24h of 
oxidative stress, compared to 0h (Fig 
2A); however, instead of a single Hsp90 
band, a second band ~70kDa was 
evidenced. While a dramatic expression 
of an Hsp90 inducible form was 
unlikely, as it would be heavier, an 
Hsp90 proteolytic cleavage was most 
probable, similarly to previous reports 
showing the appearance of a 73kDa 
band upon Hsp90c cleavage at its N-
terminal extremity [45] [46].  
To confirm, a Hsp90 N-terminal 
detecting antibody was employed, 
anticipating that no 73 kDa band would 
be evidenced at 24h. So, 100µM H2O2 
treated cells extracts were reacted with 
antibodies against HSP90 full length 
and N-terminal segment. Interestingly, 
after fluorochrome probed secondary 
antibodies detection, the full length 
antibody evidenced a double band at 84 
and 73 KDa (Fig 2B, left panel) but 
only the heavier 84 KDa band was 
labeled when the antibody against the 
N-terminal was employed instead (Fig 
2B, middle panel),. Merging both 
channels (right panel) overlay was 
evidenced only in the heavier, upper 
band, as had been shown before [46]. 
In addition, as iron was considered a co-
factor for HSP90 cleavage [46], DFO 
was used to deplete iron from cells, 
before submitting them to oxidative 
stress. As expected, in cells not 
subjected to DFO, there was HSP90 
cleavage as evidenced by the double 
band (Figure 2C, left lane); in contrast, 
in DFO treated cells, there was a single 
84 KDa band showing that Hsp90c had 
not been cleaved (Fig. 2C, right lane), 
thus confirming that the process is iron 
dependent. Moreover, employing a cell-
free system with purified recombinant 
Hsp90, it was shown that Hsp90 
cleavage is non enzymatic (Fig.2D) and 
hydrogen peroxide concentration 
dependent.  
Therefore, these data indicate that 
oxidative stress promoting conditions 
cause Hsp90 cleavage into a 73 kDa 
protein, by a non-enzymatic, iron-
dependent process.  
 
Cleaved Hsp90 accumulates as 
insoluble protein aggregates 
To further verify Hsp90 binding to the 
aggregates, two experiments were 
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made. In the first, advantage was taken 
from a previous (unpublished) study 
showing that DTT (Dithiothreitol) 
addition breaks down oxidized 
aggregates – in fact, extracts from H2O2 
treated cells grown in DTT free medium 
exhibited a strong band at the stacking 
zone of the gel that upon DDT use 
disappeared from that zone and 
appeared at the resolving gel, 
suggesting they had migrated there. In 
the current study, DTT-free cell extracts 
exhibited a 84 KDa band and an 
additional band at the stacking zone, 
which disappeared when DTT was used 
(Figure 3A, right lane). Moreover, 
Hsp90c (73 KDa) band increased 
remarkably, indicating that it was bound 
to the aggregates previously noticed at 
the stacking zone. 
The second approach departed from the 
recognition that proteins become 
insoluble upon aggregation. Extracts 
from cells studied at time point 0h and 
24h of stress were separated into two 
fractions, soluble (SF) and insoluble 
(IF), and cleaved Hsp90 was assessed. 
Quantification in the IF at 24h of stress 
revealed a 3 fold increase compared to 
0h (Fig 3B, lower chart), thus providing 
strong evidence that upon oxidative 
stress Hsp90c accumulates together 
with the aggregates as insoluble 
material. Interestingly, actin levels 
increased in the IF at 24h of stress but 
not before, further supporting the view 
that Hsp90c and actin accumulate in 
aggregates when they are fully 
established. 
 
Hsp90 cleavage antedates actin 
accumulation 
As Hsp90 plays an important role in 
oxidized proteins degradation and in 
20S proteasome protection (Whittier et 
al., 2004), we admitted that a cleaved 
Hsp90 does not prevent oxidized 
proteins, as cytoplasmic actin, to 
accumulate.  
To test that, a temporal assessment was 
made at 0h, 3h, 6h and 9h to verify actin 
and Hsp90 abundance in soluble (SF) 
and insoluble (IF) fractions. As depicted 
in Fig 4A, at each time point, actin is 
more abundant in SFs but accumulation 
in the IF starts at 6h time-point and 
continues afterwards (Fig. 4A).  
As to Hsp90c, its presence at 0h is 
probably due to the high ROS 
production by cancer cells [47-49]; 
however, later at 3h time-point, there is 
cleavage enhancement (Fig. 4B) and, 
from 6h onwards, HSP90c shifts from 
SF to IFs (Fig. 4A), confirmed by 
densitometry quantification (Fig. 4C), 
showing that it accumulates as insoluble 
material. Why Hsp90c insolubilization 
starts earlier than actin is unknown but 
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might related to its own susceptibility to 
oxidation or its binding to other, 
unknown, susceptible proteins. 
While at 24h of stress, actin aggregates 
accumulate and the proteasome function 
is impaired, at 3h such changes are 
slight, a difference that is probably 
related to the amount of oxidative 
burden imposed. In fact, a mild 
oxidation of actin and particularly its 
association with Hsp90 is useful for 
proteasome functioning, suggesting that 
the association is beneficial for protein 
degradation at the proteasome (Figure 
4D). 
 
LC3-I converts into LC3-II and 
enhances concentration at the 
insoluble fraction 
In recent years, a crosstalk between two 
major degradation systems, proteasome 
and lysosomal autophagy has been 
proposed, indicating that when the 
proteasome is inhibited, autophagy 
becomes up-regulated [50-52]. Such 
change may be studied by the 
conversion ratio of LC3-I protein into 
LC3-II [53]. In the process, LC3-I 
acquires a lipidated, SDS PAGE faster 
flowing form that is incorporated in the 
autophagosome. Due to the reduction of 
the proteasome activity at 3h and 
accumulation of oxidized protein 
aggregates at 24h [25], macroautophagy 
was tested using LC3 protein 
conversion as marker and the 
experimental conditions as referred for 
Fig. 4A. 
The western blots of soluble and 
insoluble fractions along different time-
points are displayed in Fig 5, on the left. 
The charts on the right depict LC3-
II/LC3-I ratios in soluble (Fig. 5A, left 
chart) and insoluble (Fig. 5A, right 
chart) fractions. There is an initial ratio 
increase in the soluble fraction (left 
chart), antedating its phagophore 
binding as previously suggested [54], 
and a decline after 3h time-point, 
possibly due to the lipidation 
enhancement and exhaustion of 
available soluble LC3 protein; this is in 
agreement with the Figure 5A, right 
chart, which shows a progressive LC3-
II/LC3-I ratio increase in the insoluble 
fractions, especially between 9h and 
24h (around 8-fold increase), by the 
time the aggregates are formed. 
Thus, progressive conversion from 
soluble to insoluble form suggests that, 
when proteasome inhibition establishes, 
insoluble protein aggregates 
accumulation leads to autophagosome 
formation. 
To ascertain this point, an 
immunocytochemical study was made, 
employing antibodies against LC3 and 
LAMP-1, a lysosome marker [55], and a 
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protein aggregate-binding dye in cells 
submitted to oxidative stress at 0h 
(initial experiment time-point) and 24h. 
In the experiments employing LC3 
antibody and the aggregate dye, at 0h no 
aggregates were found and the 
cytoplasmic LC3 distribution was 
uniform (Fig. 5, B1); however, at 24h, 
LC3 labeling appeared as dense spots 
that co-stained with the aggregate 
marker (right panel); interestingly, in 
other experiments (Fig. 5 B2), at 0h, 
lysosomes exhibited a fine labeling in 
the cytoplasm, similarly to the 
aggregate marker, that became intense 
and co-localized with protein aggregates 
at 24h.  
Taken together, the results point to 
autophagosome assembly, following 
protein aggregate formation and 
proteasome functional disability. 
 
Hsp90 cleavage prevention blunts 
aggregate formation and autophagy 
up-regulation 
It had been noticed that HSP90 cleavage 
is dependent on iron (Figure 2D and 
[46]). In order to test whether Hsp90 
cleavage contributes to compensatory 
autophagy up-regulation, it was blocked 
employing desferoxamine (DFO) as 
iron chelator. Cells were incubated 18h 
with 500µM DFO prior to hydrogen 
peroxide stress and extracts were 
prepared for western blotting against 
Hsp90. As expected (Fig. 6A, left), 
DFO treated cells did not exhibit Hsp90 
cleavage when compared to non DFO 
treated cells and the LC3-I conversion 
into LC3-II was blunted. In addition, an 
important role in aggregate formation 
and accumulation was shown as 
blocking Hsp90 cleavage, resulted in 
marked reduction in irreversible protein 
oxidation (Fig 6B). Moreover, in an 
immunocytochemical study, fluorescent 
labeled protein aggregates, evidenced as 
coarse intracellular areas upon H2O2 
challenging, were reduced or absent 
when treated with DFO beforehand (Fig 
6C). The relative contribution of each 
factor, iron and Hsp90, for protein 
oxidation and autophagy, although 
uncertain is relevant. In fact, only 3h 
after stress, oxidized proteins were 
increased ~1,5-fold and continued for 
24h. However, when DFO was used, the 
increase was blunted and the levels 
were similar to 0h.  
 
DISCUSSION 
In the course of cell metabolism, 
oxygen use generates a variety of by-
products that include the reactive 
oxygen species whose continued 
production subjects biomolecules to 
harmful, oxidant effect [56]. The 
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appearance of irreversibly affected 
molecules has been considered a mark 
of oxidative stress and their 
accumulation in the last third of 
organism´s life [3] is evidence in favour 
of the importance of oxidation for 
ageing. 
In cells, adding to functional 
impairment, oxidation results in protein 
structural abnormalities as unfolding. 
Consequently, usually buried 
hydrophobic domains become exposed 
and promote the establishment of cross-
links with other oxidized proteins that 
antedate the formation of insoluble 
protein aggregates [57]. These findings, 
apart from being consequences of a 
continued or intense oxidative 
environment, are features of aged cells, 
able to interfere with their metabolism, 
cause changes in gene expression and 
lead to their senescence or death. 
Aggregates have been correlated with 
aging progression across different 
models such as bacteria [58, 59], yeast 
[60], C. elegans [61] and mammalian 
cells [62]. 
The appearance of abnormal or no 
longer necessary proteins triggers a 
disposable mechanism that directs them 
for destruction at the 26S proteasome 
upon tagging by ubiquitin molecules. 
Yet, in the case that proteins are mildly 
oxidized, they may be directed through 
an additional, different process that 
targets them to the 20S proteasome, also 
aiming at cell homeostasis maintenance 
and cross-linked protein accumulation 
prevention  [8, 63, 64]. In fact, the 20S 
proteasome was considered the main 
system involved in the degradation of 
oxidized proteins [24]. In the case of 
calmodulin [18, 41] and actin (current 
study), there is evidence that oxidized 
proteins, compared to native proteins, 
are degraded by the proteasome at an 
higher rate. The nature of chemical 
changes undergone by both molecules 
emphasizes further similarity as it is the 
sulphur containing methionine residues 
in calmodulin [18] and specific cysteine 
and methionine residues of actin [65, 
66] that are sensitive to the early 
oxidative modification. 
Oxidized proteins tagged for destruction 
require the interaction with chaperones 
before they are transported to the 
proteasome. In this setting, the Hsp90 
chaperone protein is an important 
cellular tool when proteostasis is 
challenged due to its cytoplasmic 
abundance and ability to interact with a 
vast number of proteins [19]. In 
particular, Hsp90 is known to bind 
strongly to actin [29, 30] and 
calmodulin [18]. In addition, the Hsp90 
ability to enhance their degradation at 
the proteasome as shown before [18] 
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and in the current study, favors its 
involvement in their transportation. 
Hsp90, indeed, was recognized as an 
active intracellular chaperone when 
cells are affected by carbonylation [67].  
When the oxidative insult is intense, 
actin aggregates are formed [25, 66] 
(and the current data). Although they 
associate with the Hsp90 molecule, it is 
a 73KDa fragment, the Hsp90c, that 
becomes an important component of the 
aggregate, as shown in the present 
study; such cleavage is not unexpected 
as oxidative stress impinges on amino 
acid residues and may cause 
polypeptide backbone fragmentation 
[68]. In the case of Hsp90, the cleavage 
is detectable in intact cells, their lysates 
and purified recombinant proteins and is 
consequent to a non-enzymatic process 
requiring iron; this is thought to be 
chelated to adenine nucleotides and 
cause HSP90 break at an highly 
conserved N-terminal amino acid motif 
following a local Fenton reaction [46]. 
The consequences are loss of ATP 
binding domain and impairment of 
Hsp90 chaperoning function [46]. 
Moreover, the oxidative stress related 
HSP90 functional loss is likely to 
contribute to the observed proteasome 
derangement. In fact, in the current 
model of oxidative stress on Jurkat 
cells, proteasome activity reduction was 
reported as early as 3h and had 
intensified at 24h [25]. In another 
report, Hsp90 silencing was found to 
account to reduced proteasome trypsin-
like activity and Hsp90 overexpression 
was able to maintain the level of 
proteasome activity in harsh oxidizing 
conditions, suggesting a proteasome 
protective effect [23, 24]. Therefore, 
these observations, in agreement with 
previous findings [8, 13, 64], provide 
ample evidence that oxidative 
conditions impair proteasome activity. 
So, the data indicate that while mildly 
oxidized, actin in association with 
Hsp90 is conveyed to the 20S 
proteasome for degradation. However, 
under too high or prolonged oxidative 
conditions, the proteasome function 
becomes impaired, Hsp90 is cleaved 
and actin crosslink establishment is 
promoted. These events converge into a 
time-related, reduced availability of 
functional Hsp90 and enhanced 
conditions for actin insoluble 
cytoplasmic aggregates deposition. As 
the proteasome degrades oxidized but 
not aggregated proteins [57], another 
process ought to be activated to 
preserve cell viability. 
Intracellular aggregate deposits were 
long ago suggested to be a stage 
antedating their degradation at the 
lysosome compartment [69] and the 
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concept gained strength along time. In 
fact, following the proteasome 
functional decrement, such degradation 
by autophagocytosis has been shown in 
primary cells [70] and cell lines ([55], 
[71], [72]) including, now, a T cell line.  
Autophagy is a fundamental cell 
process that is triggered to remove 
intracellular abnormal molecules or 
damaged organelles. Also named 
macroautophagy [73], it refers to 
membrane encircling (phagophore) of 
intracellular material in an 
autophagosome and its submission to 
lysosome digestion. Autophagosome 
formation has been described as 
following successive stages [74] 
[38]and to foster its course, an 
increasing number of proteins has been 
uncovered. Some are activated at the 
initiation stage and others are more 
relevant at a nucleation or expansion 
stage. There, it is especially important 
the cytosolic soluble mammalian 
LC3/LC3-I protein (Atg8 in yeast) that 
reacts with a phosphoglyceride, as the 
phosphatidylethanolamine, is converted 
into the LC3-II compound and 
incorporated in the membrane of the 
autophagosome. The continued 
conversion allows LC3-II to bind more 
membrane and promote its growth to 
surround the target cellular material to 
be destroyed; LC3 members are also 
thought to contribute to the final closure 
of the phagophore membrane [74]. 
The current investigation shows that by 
9h of stress, LC3II/LC3I ratio is 
mounting and is remarkable at 24h, 
when the proteasome function is 
substantially decreased, the aggregates 
are established and cells are in a 
proliferation arrest state [25]. 
Interestingly, along this time, the LC-
II/I ratio had a transient increase in the 
soluble fraction, in agreement with 
previous observations [54], before it 
increased in the insoluble fraction and 
reached high levels at 24hours. At this 
time, either the phagophore LC3 marker 
or the lysosome LAMP-1 marker co-
localized with the aggregates, indicating 
that the cell had attained late phagocytic 
stages. 
It is noteworthy that the degradative 
process shift from proteasome to 
autophagocytosis, here reported for 
Jurkat cell line, had been noticed in 
cultured oligodendrocytes [75] and 
other lines [76]; so, the data support the 
view that autophagocytosis activation is 
a compensatory process to proteasome 
functional decrement[76]. Interesting 
too is the reverse effect reported in 
colon cancer cells, where inhibition or 
silencing of a variety of 
autophagocytosis genes resulted in 
enhanced proteasome activity[77], thus 
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enriching the crosstalk ability of these 
degradation systems. 
The proliferative arrest and reduced 
functional capacity of the proteasome 
observed in this cell Jurkat cell line has 
a parallel with a previous report with 
primary T cells [26, 27], whose changes 
were interpreted as consequent to 
immune cells ageing. In fact, there is 
substantial evidence in favor of an age 
related and cell senescence related 
decrement in proteasome activity [78] 
As the silencing of important genes 
involved in autophagocytosis results in 
enhanced cell vulnerability to the 
oxidative insult [57, 79] and in fact the 
phagocytic process ameliorates cell 
resistance to apoptosis and other 
stresses [80, 81], we are convinced 
(shown in Fig.7) that early Hsp90 
chaperoning ability loss upon cleavage 
and proteasome reduced functioning are 
the primer events that lead to protein 
aggregates formation, which in turn 
results, in the activation of 
autophagocytosis as protective 
mechanism of a larger process for cell 
survival. 
 
LEGENDS TO FIGURES 
Figure 1. In oxidative stressful 
conditions, Hsp90c accumulates in 
actin containing protein aggregates.  
In a previous report [25] it was shown 
that submitting Jurkat cells to 100 μM 
hydrogen peroxide for 24h results in the 
formation of insoluble actin aggregates. 
The conditions were repeated and 
compared to 0h exposure controls. 
(A) At 24h of stress, fluorescence 
detection of Hsp90 protein (green 
labeling) and cell aggregate (red 
labeling) revealed a remarkable co-
localization, this was not seen at 0h. 
(B) Hsp90 accumulates in actin 
aggregates as evidenced by confocal 
microscopy detection of Hsp90 (green) 
and actin (red). While Hsp90 exhibits a 
fairly homogeneous, cell-wide 
distribution, actin is mostly localized to 
the periphery, near the cell membrane 
(left panels). Upon 24h of hydrogen 
peroxide use, Hsp90 and actin co-
localize and frequently exhibit 
aggregates (arrows at right panels). 
 
Figure 2. Oxidative stress promoted 
Hsp90 chaperone cleavage into 
Hsp90c is dependent on iron and 
oxidant intensity. 
(A) Jurkat cells were exposed to 100 
μM hydrogen peroxide for 24h and 
compared to controls (0h exposure). 
Immunoblots were prepared with 
antibodies against full length 84 kDa 
Hsp90 (top image), and their respective 
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densitomety was quantified (bottom 
chart). Upon exposure, Hsp90 level 
decreased ~50% and a new 73 KDa 
band appeared, consequent to Hsp90 N-
terminal cleavage, identified as Hsp90c. 
Quantification of Hsp90 and Hsp90c is 
the result of three independent 
experiments (Mean ± standard 
deviation, SD).  
(B) Extracts of Jurkat cells submitted to 
100 μM hydrogen peroxide for 24h 
were immunobloted employing Hsp90 
full length and Hsp90 N-terminal 
specific antibodies. Detection was made 
with secondary antibodies bearing 
different fluorochromes. Full length 
antibody evidenced two bands, as in 
(A), whereas the N-terminal antibody, 
demonstrated one single 84 kDa band, 
indicating that Hsp90c band resulted 
from N-terminal Hsp90 cleavage. 
Overlay signal co-localizes only in the 
84 kDa band, thus showing that the 73 
KDa protein lacks the N-terminal 
fraction. Membrane fluorescence was 
detected with Li-Cor Odyssey. 
(C) Iron is required for Hsp90 cleavage. 
Cells depleted in iron upon DFO use do 
not exhibit Hsp90c even when exposed 
to hydrogen peroxide for 24h (right 
lane). In contrast, exposed cells without 
iron depletion, showed the expected 
double band pattern (left lane). 
(D) Hsp90 cleavage in a cell free 
system. Hsp90 was subjected to 
hydrogen peroxide at two different 
concentrations (0.1 and 0.2 mM) in the 
presence of ADP and FeCl3. Oxidant 
concentration dependent cleavage is 
evidenced again at this simple system 
and confirms that Hsp90c results from 
N-terminal Hsp90 cleavage.  
 
Figure 3. Hsp90c, accumulates as 
insoluble aggregates 
(A) Hsp90c is present in aggregates. 
Upon Jurkat cells exposured to 100 μM 
hydrogen peroxide in a medium without 
or with the aggregate dissolving agent 
DTT, western blots were probed with 
the full length anti Hsp90 antibody. In 
conditions without DTT, a band is 
retained at the stacking gel and the 
73KDa protein is faint or missing (left 
lane); when DTT is added, aggregates 
dissolve and migrate into the resolving 
gel (right lane), where they exhibit the 
84 KDa and the 73 KDa bands, 
indicating that the Hsp90c previously 
retained in aggregates migrated to the 
stacking gel. Blot is representative of 3 
different experiments. 
(B) Hsp90c is localized to the insoluble 
fraction. Jurkat cells were exposed to 
100 μM hydrogen peroxide for 24h and 
compared to controls (0h exposure). 
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Total protein extracts samples from 
time-point 0h and 24h of oxidative 
challenge were separated as soluble 
(SF) and as insoluble (IF) fractions. 
Hsp90c shows a >3-fold content 
increase in the insoluble fraction upon 
oxidative stress (lower chart) supporting 
the view that it binds to protein 
aggregates. Also noteworthy, is the 
increased actin level in the IF after 24h 
of hydrogen peroxide. Blot is 
representative of 3 different 
experiments. 
 
Figure 4. Oxidative stress related 
Hsp90c appearance is time-dependent 
and localizes in the cytoplasmic 
insoluble fraction.  
Upon cell exposure to 100 μM 
hydrogen peroxide, samples were 
collected at 3h, 6h, and 9h and 
compared to controls (0h).  
(A) Extracts from controls and treated 
cells were prepared for separation of 
soluble and insoluble fractions. 
Oxidative conditions promote Hsp90 
cleavage, already evident at 3h. Hsp90c 
form remains in the cytoplasmic soluble 
fraction until 6h, when it shifts towards 
insolubility, which is notorious at 9h 
post stress. Ponceau S staining (PS, 
bottom image) and western blots with 
antibodies against full length Hsp90 
(middle image) and actin (top image) 
are depicted in this representative 
image.  
(B) Quantification of Hsp90c at the 
soluble fraction confirms that it is 
already enhanced at 3h.  
(C) Quantification of relative % of actin 
(right graph) and Hsp90c (left graph) in 
soluble (SF) and insoluble (IF) 
fractions. Actin level increases in the 
insoluble fraction, after time point 6h, 
when Hsp90c had already accumulated 
considerably and when aggregate 
formation is likely to begin. It thus 
indicates that Hsp90 cleavage and 
accumulation at the IF precedes actin 
accumulation. Graphic bars result from 
three independent experiments (Mean ± 
SD are shown). 
(D) Hsp90 enhances proteasome 
activity in vitro. In a cell free system, 
proteasome activity was measured after 
adding to the medium actin, oxidized 
actin, oxidized actin plus Hsp90 and 
Hsp90 only. Activity was normalized to 
100% in the condition of actin only and 
compared. Oxidized actin promotes 
proteasome activity 2 fold (200%), 
further enhanced to 3 fold when 
oxidized actin is incubated along with 
Hsp90. 
 
Figure 5. Oxidative stress promoted 
protein aggregates lead to 
autophagosome formation.  
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Jurkat cells were exposed to 100 μM 
hydrogen peroxide for up to 24h; 
samples were collected at 3h, 6h, 9h and 
24h and compared to controls (0h). 
(A) Cell samples were processed for 
soluble (SF) and insoluble (IF) 
cytoplasmic fractions; immunoblots 
(upper figure) were prepared against 
LC3 (LC3-I) protein that converts into 
its lipidated form (LC3-II) when 
autophagy is up-regulated. Data show 
that LC3-I conversion into LC3-II is 
time related, as evidenced by comparing 
0h (basal) through 24h (stress time), and 
also shows that LC3-II shifts from the 
SF to the IF, suggesting its binding to 
the phagophore. The perception from 
the visual inspection of the blot is 
confirmed upon densitometric 
assessment of LC3-II/LC3-I ratios in SF 
and IF (charts on the right). 
(B) Immunocytochemical study of 
Jurkat cells at 0h (upper images) and 
upon 24h (bottom images) exposure to 
hydrogen peroxide. (B1) Cells were 
labeled for LC3 (left images) and 
aggregate marker (middle images) and 
co-localization was verified (right). At 
0h, LC3 protein has an uniform 
distribution inside the cell and 
aggregate labeling is residual whereas at 
24h (bottom images) LC3 protein 
concentrates in dense areas that co-
localize with the aggregate marker. (B2) 
The lysosome marker LAMP-1 (left 
images) and the aggregate marker 
(middle) co-localize (right image) at 
24h upon hydrogen peroxide treatment. 
The data indicate that aggregate 
formation results in autolysosome build-
up, as evidenced by promotion of LC3 
protein conversion into LC3-II insoluble 
form and its co-localization with the 
lysosomal LAMP-1. This is strong 
evidence in favor of autophagosome-
lysosome axis activation after protein 
aggregates formation.  
 
Figure 6. Desferoxamine (DFO) 
prevents Hsp90 cleavage and 
autophagy up-regulation.  
Hsp90 cleavage prevention was 
achieved by adding DFO 500µM to the 
media 18h before inducing oxidative 
stress with 100 μM hydrogen peroxide. 
(A) DFO prevented Hsp90 cleavage 
(upper blot) and strongly inhibited the 
conversion of LC3-I to LC3-II (bottom 
blot); Ponceau S (PS) image is at the 
right. The data show that iron is 
necessary for Hsp90 cleavage, which 
appears to be part of a process that 
results in protein aggregate 
accumulation, proteasome inhibition 
and promotes autophagy up-regulation. 
(B) Depleting iron with DFO before 
oxidative stress, prevents the increase in 
carbonylated proteins. This can be 
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followed after 3h, 9h, 24h of oxidative 
stress with or without DFO.  
(C) Jurkat cell controls (left image) or 
exposed to 100 μM hydrogen peroxide 
for 24h, without (center image) or with 
(right image) previous addition of DFO. 
Upon oxidative challenge, aggregates 
accumulate (red labeling, center image), 
which is prevented by previous DFO 
treatment. 
 
Figure 7. Proposed events for protein 
aggregates, proteasome inhibiton and 
autophagy upregulation. When Hsp90 
is fully functional (full length protein) it 
will assist and enhance oxidized 
proteins degradation (oxidized actin 
included) by the 20S proteasome 
avoiding or simply delaying their 
accumulation as protein aggregates. 
However, if Hsp90 gets cleaved during 
oxidative stress it will become less 
functional. Therefore, it will bind 
oxidized proteins, but because it lacks 
the N-terminal it cannot assist correctly 
oxidized proteins turnover. They start to 
accumulate along with cleaved Hsp90 
originating protein aggregates, which 
later on, will bind to proteasome surface 
motifs, inhibiting its enzymatic activity. 
In an attempt to solve or compensate 
proteasome activity decrease, cells 
upregulate autophagy shown by the 
formation of the phagophore that will 
engulf protein aggregates. They are 
forward to lysosomes to clear the toxic 
cargo. 
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DISCUSSION 
Oxidative stress occurs when there is a disruption in the balance between oxidants and 
anti-oxidants, in the favor of the former [1]; its consequences have fulfilled much of the 
life sciences scientific agenda in the last decades. Why did such theme become so 
interesting to science? The main reason is the implication of oxidative stress in ageing 
progression and disease [2]. It affects biomolecules such as DNA, sugars, lipids and, 
most importantly, proteins; indeed when oxidative stress impinges on them, it impairs 
their functions and causes cellular disorders, which can range from reversible to 
irreversible. A frequent outcome of irreversible oxidation is protein carbonylation, a 
non-enzymatic event [2-4], that is able to accumulate and, therefore, be harmful. 
 
1.1 Oxidized actin aggregates formation and proteasome impairment 
Protein carbonylation increase is a recurrent phenomenon in human ageing or disease. 
Aggregates, following protein oxidation, have been deeply correlated with ageing across 
different models such as bacteria [5, 6], yeast [7], C. elegans [8] and even mammalian 
cells [9]. Their formation, previously described in Introduction Section 2, may be thus 
elicited by oxidative stressful conditions as those employed in the current investigation. 
To prevent aggregates formation and assure proteostasis, cells degrade carbonylated 
proteins employing the proteasome, considered the most efficient mechanism for their 
turnover [10, 11]. Therefore, if the proteasome is impaired or carbonylated proteins 
formation rate overwhelms the proteasome capacity for degradation, they can aggregate 
and accumulate [12]. This is an important issue because aggregates are harmful due to 
their ability to interfere with cellular metabolism, cause changes in gene expression, 
additional proteasome inhibition and lead to cell senescence or cell death [13-15]. 
I found that upon Jurkat cells hydrogen peroxide challenging, there is formation of 
oxidized actin aggregates in a time and dose dependent pattern. In fact, while absent at 
three hours upon oxidative stress, they accumulate at 24h, a time when proliferation 
arrest and proteasome inhibition were evidenced too [12]. Such changes may result 
from a direct effect of aggregates, noticed when I incubated cells with in vitro made 
oxidized actin aggregates without added hydrogen peroxide. 
Thus, if not degraded efficiently by the proteasome, oxidized proteins accumulate as 
insoluble high molecular weight protein aggregates that interfere with important cellular 
functions [13-15]. Interestingly, the accumulation of abnormal molecules, proteasome 
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reduced functioning and proliferation arrest are major findings in human senescent skin 
fibroblasts [16, 17]. The similar changes evidenced in Jurkat cells thus favor the view 
that they are also occurring in in vivo, aged T lymphocytes. In fact, senescent cells 
increase in organisms over time [18], and immune cells appear to accompany so. In 
humans, such changes include reduction of naïve T-cell production, either CD4
+
 and 
CD8
+
, and clonal expansion of speciﬁc CD8 T-lymphocyte subsets as the CD8+ CD28– 
[19]. Such CD8
+
 cells are particularly prone to oxidation [20] and when cultured, they 
acquire a senescent like phenotype including growth arrest [21].  
Adding to these changes, I found that proteasome function was impaired, which is 
another feature of aged and senescent T cells in vivo and was proposed as contributor to 
immunosenescence mechanisms [22, 23]. Similarly, carbonylated proteins accumulation 
and less rounds of proliferation were found in lymphocytes of ad libitum fed aged mice 
when compared to animals submitted to calorie restriction, a condition known to extend 
lifespan [24].  
There is thus a considerable amount of data that relate cell senescence to oxidized 
protein accumulation, proteasome functional decrement and proliferative impairment. I 
noticed parallel findings in the oxidatively stressed model of Jurkat cells, therefore 
supporting the view that this model mimicks important effects of ageing on cells. 
 
1.2 Hsp90 cleavage leads to insoluble actin accumulation 
Although protein aggregates accumulation is a frequent finding upon oxidative stress, 
and the proteasome impairment is a contributor, the mechanism why cells fail to 
degrade them is still debatable. 
To avoid proteostasis disruption, cells have molecular chaperones that promote oxidized 
proteins destruction. An example of a key player is the highly conserved and abundant 
molecular chaperone Hsp90 [25]. It is composed of three distinct domains, the N-
terminal, a middle domain and C-terminal. The N-terminal is responsible for ATP 
hydrolysis, required for substrate remodeling, and the middle domain has a role in 
substrate binding, whereas the C-terminal is necessary for Hsp90 dimerization and co-
chaperones binding [25]. 
Hsp90 has a high affinity to its clientele proteins but the nature of interaction can be 
diverse because it binds to unfolded, native proteins, as well as damaged proteins, and 
requires additional factors, as co-chaperones [25].  
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Hsp90 is itself sensitive to oxidative stress and is cleaved by several oxidants at a highly 
conserved N-terminal amino acid motif [26] which originates a N-terminal deprived 
73kDa fragment (Hsp90c unable to bind ADP or ATP). This was observed in intact 
cells, cell lysates, and when purified recombinant proteins were employed, indicating an 
unlikely protease involvement [26]. This point was verified in the current investigation 
with Jurkat cells extracts and cell free experiments, but it was also shown that Hsp90 
cleavage is dependent on iron [26] (Fig. 5) because when DFO, iron is chelated and the 
cleavage is prevented. 
The accumulation of oxidized proteins can be attributed not only to their hydrophobic 
residues binding, but also to lesser 20S proteasome degradation events, shown to be 
enhanced when Hsp90 is present [27]. In fact, in my in vitro studies with the 
proteasome, I found that oxidized actin degradation rate was two-fold higher when 
compared to non-oxidized actin; however, when purified Hsp90 was added to the 
experiment, the rate was even higher, providing evidence in favor of Hsp90 role in 
assisting and enhancing oxidized proteins turnover. But such role likely extends to the 
proteasome itself. Interestingly, when the stress was imposed in Hsp90 overexpressing 
cells or onto purified 20S proteasome or cellular extracts artificially contaminated with 
Hsp90, the proteasome activity was found conserved, suggesting that Hsp90 is a 
proteasome protector [28-30]. Because the data do not favor the cleavage as amenable 
to intracellular regulation, it is thus a major challenge to cells. Indeed, Hsp90 cleavage 
appears to be determinant for decreased proteasome protection and for reduced or 
abnormal transportation of oxidized proteins to be degraded, conditions that make of 
protein aggregates an inevitable consequence. 
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Figure 5. Hsp90 cleavage leads to a less functional protein. Hsp90 N-terminal binds ADP which 
converts into ATP when the chaperone activity is required (1). ADP has affinity for iron that, under 
oxidative stressful conditions acts as a co-factor in the H2O2 conversion into OH
- (Fenton reaction); the 
reactivity of OH
- 
impinges on some amino acids in the N-terminal generation a 73kDa protein fragment 
(2). As it lacks ATP binding domain, it is no longer fully functional (3). If iron is depleted from cells 
using iron chelators such as DFO, the cleavage is prevented.
 
 
1.3 Proteasome inhibition and protein aggregates lead to autophagy upregulation 
The two major proteolytic degradation systems are the proteasome and the lysosome, 
which has a major role in the autophagy mechanism (described in the Introduction 
subchapter “Crosstalk between proteasome and lysosomal autophagy”, and in [31]). In 
addition, there is evidence that autophagosome formation becomes upregulated when 
the proteasome is inhibited, although the opposite may not always be true. 
Fortun et al. demonstrated that after proteasome inhibition, Peripheral Myelin Protein 
22 (PMP22) aggregates form and recruit autophagosomes for lysosome mediated 
autophagy clearance [32]. Moreover, similarly to my own observations, Lazaro-Diegues 
et al have shown that jasplakinolide induced F-actin aggregates inhibited the 
chymotrypsin-like activity of the proteasome and were able to trigger the lysosomal 
autophagic system [33]. Adding to this, 17-AAG, a proteasome inhibitor, induced 
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cytoplasmic α-synuclein aggregates, that were cleared by the induction of autophagy 
[34]. These studies account in support of intertwined turnover mechanisms. 
Autophagy is a fundamental cell process, triggered to remove intracellular abnormal 
molecules or damaged organelles [35]. Autophagosome formation has been described as 
following successive stages [31, 36] and to foster its course, an increasing number of 
proteins has been uncovered. Some are activated at the initiation stage whereas others 
are more relevant at a nucleation or expansion stage. At that point, it is especially 
important the cytosolic soluble mammalian LC3/LC3-I protein (Atg8 in yeast) that 
reacts with a phosphoglyceride, as the phosphatidylethanolamine, is converted into the 
LC3-II compound and is incorporated in the membrane of the autophagosome. The 
continued conversion allows LC3-II to bind more membrane and promote its growth to 
surround the cellular material targeted to be destroyed; LC3 members are also thought 
to contribute to the final closure of the phagophore membrane [31]. 
My investigation showed that by 9h of stress, LC3II/LC3I ratio is mounting to become 
remarkable at 24h, when the proteasome function is substantially decreased, the 
aggregates are established and cells are in a proliferation arrest state [12]. Interestingly,  
the LC-II/I ratio had an early transient increase in the soluble fraction, in agreement 
with previous observations [37], before it increased in the insoluble fraction. At this 
later time, either the phagophore LC3 marker or the late phagocytic stage lysosome 
LAMP-1 marker co-localized with the aggregates. Similarly, to our cells, in cultured 
oligodendrocytes with functionally impaired proteasome, it was reported that the 
autophagic marker LC3-II was upregulated and was recruited to the growing protein 
aggregates [38]. In addition, in CD8
+
 replicative senescent lymphocytes accumulating 
lipofuscin [39] and in other aged cells with reduced proteasome activity [35, 40, 41] 
autophagy was found activated. 
All these findings, in different experimental conditions, favor the view that when the 
proteasome becomes impaired, there is compensatory autophagy activation. Why should 
this occur is currently unknown but it may be related to intracellular sensors of 
proteasome impairment or protein aggregate accumulation that are activated in order to 
avoid further damage.  
Autophagy requires a considerable amount of proteins whose study has shown to be far 
more important than previously thought. For example, Atg5 protein deficient cells, 
obtained by silencing or knocking out technical approaches, exhibit remarkable 
autophagy impairment and lipofuscin accumulation. This non-degradable material 
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present in the cytosol leads to increased ROS production and cell viability loss [42]. In 
contrast, autophagy enhancement was found to rescue Hela cells undergoing apoptosis 
[43]. Therefore, macroautophagy is not only a protective mechanism to prevent protein 
aggregates toxic effects [42] but also appears to be a fundamental survival process that 
is activated under extreme conditions [43]. 
 
 
 
 
Figure 6. Oxidative promoted Hsp90 cleavage correlates with protein aggregates, proteasome 
inhibiton and autophagy upregulation. Supported by data our hypothesis points to a chain of events, 
starting with Hsp90 cleavage. In fact, functional Hsp90 (1) assists oxidized proteins (including actin) 
degradation (2) thus by the 20S proteasome delaying or avoiding their accumulation as protein 
aggregates. However, if Hsp90 gets N-terminally cleaved during oxidative stress (3), it loses functional 
capacities, although it binds to oxidized proteins (4). Hsp90c bound oxidized proteins accumulate which 
originates protein aggregates that later bind proteasome surface motifs and inhibit its enzymatic activity 
(5). To compensate the activity decrease, cells upregulate autophagy and form the phagosome that will 
engulf aggregates and fuses with lysosomes (6). 
  
In short, for the first time, I report that the oxidation sensitive actin forms aggregates 
following Hsp90 cleavage and proteasome inhibition. These events lead to proliferation 
arrest and autophagy up-regulation as depicted in Fig.6. Although, here described in a 
lymphocyte cell line model, I am convinced that they are extensive to other cells and 
therefore relevant for the study of cellular senescence. 
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MAIN CONCLUSIONS 
I. Oxidative stressful conditions result in Jurkat cell decreased functionality as 
evidenced by impairment of proteostasis and cell proliferation without viability 
loss 
II. Time and intensity dependent oxidative stressful conditions lead to proteasome 
reduced activity, enhanced actin carbonylation and susceptibility to aggregate 
formation 
III. Aggregate formation and accumulation are the likely result of actin (and other 
oxidized proteins) chaperone inability to convey oxidized actin for destruction at 
the 20S proteasome, consequent to oxidative stress dependent cleavage into the 
non-functional Hsp90c form 
IV. Proteasome dependent proteostasis impairment antedates autophagy increase as 
a likely compensatory mechanism. 
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